<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004854.pub2" GROUP_ID="DEPRESSN" ID="519203090414594121" MERGED_FROM="" MODIFIED="2008-11-02 00:39:50 +0100" MODIFIED_BY="Rachel Churchill" NOTES="&lt;p&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-01 23:35:14 +0000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="148" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2008-11-02 00:39:50 +0100" MODIFIED_BY="Rachel Churchill">
<TITLE>Interventions for helping people recognise early signs of recurrence in bipolar disorder</TITLE>
<CONTACT MODIFIED="2008-11-02 00:39:50 +0100" MODIFIED_BY="Rachel Churchill"><PERSON ID="11851F0182E26AA201DC7B3ED8E7801A" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Richard</FIRST_NAME><LAST_NAME>Morriss</LAST_NAME><POSITION>Professor of Psychiatry</POSITION><EMAIL_1>richard.morriss@nottingham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>University of Nottingham </ORGANISATION><ADDRESS_1>A Floor, South Block</ADDRESS_1><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>0115 8230427</PHONE_1><FAX_1>0115 8230433</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-11-02 00:39:50 +0100" MODIFIED_BY="Rachel Churchill"><PERSON ID="11851F0182E26AA201DC7B3ED8E7801A" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Richard</FIRST_NAME><LAST_NAME>Morriss</LAST_NAME><POSITION>Professor of Psychiatry</POSITION><EMAIL_1>richard.morriss@nottingham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>University of Nottingham </ORGANISATION><ADDRESS_1>A Floor, South Block</ADDRESS_1><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>0115 8230427</PHONE_1><FAX_1>0115 8230433</FAX_1></ADDRESS></PERSON><PERSON ID="1184F77482E26AA201DC7B3EFA029318" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mohammad</FIRST_NAME><MIDDLE_INITIALS>Amir</MIDDLE_INITIALS><LAST_NAME>Faizal</LAST_NAME><POSITION>Senior House Officer</POSITION><EMAIL_1>Faizal72@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Psychiatry</DEPARTMENT><ORGANISATION>Mersey Care NHS Trust</ORGANISATION><CITY>Liverpool</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="11583" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Ashley</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Jones</LAST_NAME><POSITION>Medical Statistician</POSITION><EMAIL_1>apjones@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Child Health</DEPARTMENT><ORGANISATION>University of Liverpool</ORGANISATION><ADDRESS_1>Alder Hey Children's Hospital</ADDRESS_1><ADDRESS_2>Eaton Road</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L12 2AP</ZIP><REGION>Merseyside</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 282 4524</PHONE_1><FAX_1>+44 151 252 5456</FAX_1></ADDRESS></PERSON><PERSON ID="8314" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Paula</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Williamson</LAST_NAME><EMAIL_1>prw@liv.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Centre for Medical Statistics and Health Evaluation</DEPARTMENT><ORGANISATION>University of Liverpool</ORGANISATION><ADDRESS_1>Shelley's Cottage</ADDRESS_1><ADDRESS_2>Brownlow Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L69 3GS</ZIP><REGION>Merseyside</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 794 4760</PHONE_1><FAX_1>+44 151 794 4754</FAX_1></ADDRESS></PERSON><PERSON ID="19960" ROLE="AUTHOR"><FIRST_NAME>Catherine</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Bolton</LAST_NAME><POSITION>Clinical Psychologist</POSITION><EMAIL_1>Catherinebolton1@aol.com</EMAIL_1><ADDRESS><DEPARTMENT>Child and Adolescent Mental Health Service</DEPARTMENT><ORGANISATION>Royal Bolton Hospital Trust</ORGANISATION><ADDRESS_1>Child and Adolescent Mental Health (CAMHS)</ADDRESS_1><ADDRESS_2>Royal Bolton Hospital MInerva Road</ADDRESS_2><CITY>Bolton</CITY><REGION>Lancashire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1204 390659</PHONE_1></ADDRESS></PERSON><PERSON ID="118519B282E26AA201DC7B3EDC7DFA04" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>James</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>McCarthy</LAST_NAME><POSITION>Consultant Psychiatrist</POSITION><EMAIL_1>jpmccar@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Ferndale Unit</DEPARTMENT><ORGANISATION>Merseycare NHS Trust</ORGANISATION><ADDRESS_1>Ferndale Unit, University Hospital Aintree</ADDRESS_1><ADDRESS_2>Longmoor Lane</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L9 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 529 3066</PHONE_1><FAX_1>+44 151 529 3063</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-11-02 00:39:50 +0100" MODIFIED_BY="Rachel Churchill" NOTES="&lt;p&gt;Minor update: 20/04/06&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 20/10/05&lt;/p&gt;" NOTES_MODIFIED="2008-11-01 23:35:14 +0000" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="30" MONTH="10" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="20" MONTH="10" YEAR="2005"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="11" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="1" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="30" MONTH="10" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Liverpool</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Mersey Care NHS Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT>
<SUMMARY>
<TITLE>Interventions for helping people recognise early signs of recurrence in bipolar disorder</TITLE>
<SUMMARY_BODY>
<P>Bipolar disorder (BPD), or manic-depressive psychosis, is a common and severe mental illness, with a lifetime prevalence of 1-2%. BPD is characterised by two types of recurrence, mania and depression. High rates of recurrence and associated adverse consequences occur in spite of a range of effective treatments. Early warning signs (EWS) interventions, targeted at improving the recognition and self-management of manic and depressive symptoms, are intended to train people with recurrent bipolar affective disorder to recognise early warning signs of recurrence and to avert adverse outcomes. This review demonstrated that these interventions, in addition to treatment as usual (TAU), including medication and regular appointments with health professionals, have benefits on time to recurrence and hospitalisation. Compared with TAU only, EWS interventions also resulted in improved functioning at eighteen months, although these data were sparse and the findings should be interpreted with caution. EWS interventions did not appear to have any effect on depressive or manic symptoms, although again, these findings were based on small numbers of potentially selected patients in remission. It should be noted that EWS was used along with other psychological interventions, and it is not entirely clear what proportion of the beneficial effect was due to the EWS intervention alone.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Recurrence rates for bipolar disorder are high despite effective treatments with mood stabiliser drugs. Self-help treatments and psychological treatments that teach patients to recognise and manage early warning symptoms and signs (EWS) of impending manic or depressive episodes are popular with patients. The main aim of such interventions is to intervene early and prevent bipolar episodes, thereby increasing the time to the next recurrence and preventing hospitalisation. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare the effectiveness of an EWS intervention plus treatment as usual (TAU ) versus TAU (involving and not involving a psychological therapy) on time to manic, depressive and all bipolar episodes (the primary outcome), hospitalisation, functioning, depressive and manic symptoms.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>Relevant studies identified by searching Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References - searched on 20/10/2005), supplemented with hand searching the journal Bipolar Disorders, searching the UK National Research Register, checking reference lists of included studies and contacting authors.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Only randomised controlled trials (RCTs) were included. Participants were adults with a diagnosis of bipolar disorder based on standardised psychiatric criteria. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers independently rated trials for inclusion. Data were extracted from included trials by reviewers using a data extraction sheet. Authors of all the included studies were contacted for any additional information required. Time to recurrence data was summarised as log hazard ratios, dichotomous data as relative risk and continuous data as weighted mean difference, using random effects models to calculate effect size only when there was heterogeneity in the data. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Eleven RCTs were identified, but only six provided primary outcome data. All six RCTs were of high quality. Time to first recurrence of any type (RE, hazards ratio 0.57, 95% CI 0.39 to 0.82), time to manic/hypomanic episode, time to depressive episode, and percentage of people hospitalised and functioning favoured the intervention group. Neither depressive nor hypomanic symptoms differed between intervention and control groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>This review shows a beneficial effect of EWS in time to recurrence, percentage of people hospitalised and functioning in people with bipolar disorder. However, the absence of data on the primary outcome measure in so many included studies is a source of concern and a potential source of bias. Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder, as they appear to reduce hospitalisation and therefore may be cost-effective.<BR/> </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P>Bipolar disorder (BPD), or manic-depressive psychosis, is a common and severe mental illness with a lifetime prevalence of one to two per cent (<LINK REF="REF-Robins-1984" TYPE="REFERENCE">Robins 1984</LINK>; <LINK REF="REF-ten-Have-2002" TYPE="REFERENCE">ten Have 2002</LINK> ). BPD is characterised by two types of recurrence, mania and depression. Mania is characterised by periods of elation or irritable mood lasting at least four days, coupled with other symptoms of overactivity, reduced need for sleep, disinhibition, increased self-esteem or grandiosity and increased talkativeness (<LINK REF="REF-APA-1995" TYPE="REFERENCE">APA 1995</LINK>). Depression is characterised by core symptoms of depressed mood and loss of interest for at least two weeks, coupled with other symptoms such as changes in sleep pattern, appetite and concentration, low self-esteem, hopelessness, self-blame and suicidal ideation. Psychotic symptoms such as delusions and hallucinations are seen in a substantial proportion of patients in either the manic or depressed phases of the disorder. Recurrence rates are high, at around 50 per cent at one year, and 70 per cent at four years (<LINK REF="REF-Coryell-1989" TYPE="REFERENCE">Coryell 1989</LINK>; <LINK REF="REF-Harrow-1990" TYPE="REFERENCE">Harrow 1990</LINK>; <LINK REF="REF-Tohen-1990" TYPE="REFERENCE">Tohen 1990</LINK>; <LINK REF="REF-O_x0027_Connell-1991" TYPE="REFERENCE">O'Connell 1991</LINK>; <LINK REF="REF-Keller-1992" TYPE="REFERENCE">Keller 1992</LINK>; <LINK REF="REF-Gitlin-1995" TYPE="REFERENCE">Gitlin 1995</LINK>) after a manic episode, in modern naturalistic studies. BPD patients were found to be symptomatic with recurrence or inter-episode symptoms of mania or depression for 47 per cent over a mean follow up of 13 years (<LINK REF="REF-Judd-2002" TYPE="REFERENCE">Judd 2002</LINK>). Recurrence and inter-episode symptoms impair function, marital relationships, employment and quality of life (<LINK REF="REF-Gitlin-1995" TYPE="REFERENCE">Gitlin 1995</LINK>; <LINK REF="REF-Ozer-2002" TYPE="REFERENCE">Ozer 2002</LINK>; <LINK REF="REF-Judd-2002" TYPE="REFERENCE">Judd 2002</LINK>). There is a high lifetime prevalence of attempted suicide rate, completed suicide, and also risks to others through violence, neglect of dependents or reckless behaviour (<LINK REF="REF-Goodwin-1990" TYPE="REFERENCE">Goodwin 1990</LINK>; <LINK REF="REF-Morriss-2002" TYPE="REFERENCE">Morriss 2002</LINK>).</P>
<P>High rates of recurrence and their adverse consequences occur in spite of a range of effective treatments such as mood stabilisers (<LINK REF="REF-Bowden-2000" TYPE="REFERENCE">Bowden 2000</LINK>; <LINK REF="REF-Burgess-2003" TYPE="REFERENCE">Burgess 2003</LINK>). Surveys of patient organisations in UK and US reveal a strong wish by patients for both self-help and psychological treatments in addition to pharmacotherapy (<LINK REF="REF-Lish-1994" TYPE="REFERENCE">Lish 1994</LINK>; <LINK REF="REF-Hill-1996" TYPE="REFERENCE">Hill 1996</LINK>). Self-help treatments may empower patients and enable them to take more control over their care and life decisions. </P>
<P>One form of self-help treatment and psychological intervention is to teach BPD patients to recognise early signs of the recurrence of mania and depression (<LINK REF="REF-Perry-1995" TYPE="REFERENCE">Perry 1995</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). This type of secondary prevention is widely used in medicine e.g. to promote early treatment of hypoglycaemia in diabetes mellitus or myocardial infarction. The approach has been practiced for many years in BPD patients (<LINK REF="REF-Jacobson-1965" TYPE="REFERENCE">Jacobson 1965</LINK>). Three retrospective studies (<LINK REF="REF-Molnar-1988" TYPE="REFERENCE">Molnar 1988</LINK>; <LINK REF="REF-Smith-1992" TYPE="REFERENCE">Smith 1992</LINK>; <LINK REF="REF-Lam-1997" TYPE="REFERENCE">Lam 1997</LINK>) and two prospective studies (<LINK REF="REF-Altman-1992" TYPE="REFERENCE">Altman 1992</LINK>; <LINK REF="REF-Keller-1992" TYPE="REFERENCE">Keller 1992</LINK>) showed identifiable and consistent early or "prodromal" symptoms of manic or depressive recurrence at two to four weeks before full recurrence in most patients with BPD. These prodromal symptoms are idiosyncratic to both the individual and type of recurrence (mania or depression). They may be more consistent and easier to recognise for mania than depression (<LINK REF="REF-Molnar-1988" TYPE="REFERENCE">Molnar 1988</LINK> , <LINK REF="REF-Smith-1992" TYPE="REFERENCE">Smith 1992</LINK>). The definition of prodromal symptoms that represent the focus of the present review is early warning signs (EWS) of impending recurrence for persons already diagnosed with bipolar disorder. These prodromal symptoms are distinct in definition from those prodromal changes that precede the initial onset of major mental disorder (<LINK REF="REF-Bustillo-1995" TYPE="REFERENCE">Bustillo 1995</LINK>).</P>
<P>Individuals who cope well with the prodromal symptoms of mania and depression are less likely to be hospitalised (<LINK REF="REF-Joyce-1985" TYPE="REFERENCE">Joyce 1985</LINK>) and show improved social and occupational function (<LINK REF="REF-Lam-1997" TYPE="REFERENCE">Lam 1997</LINK>). Cognitive behaviour therapy targeted at improving the recognition and self-management of manic and depressive prodromes has been reported as effective in delaying both depressive and manic recurrence (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>). Recognition of EWS may also avert adverse outcomes. For instance, in the event of an episode, plans can be made for child care so that children are not neglected, for financial control to prevent reckless spending, and avoidance of previous circumstances that in the past have led to violence or re-offending. </P>
<P>Adverse outcomes from self-monitoring of early recurrences of BPD have been reported, with interventions involving the identification and management of EWS (<LINK REF="REF-Morriss-2004" TYPE="REFERENCE">Morriss 2004</LINK>). Patients may become over-confident that they can use these techniques to prevent recurrence, and stop their mood-stabilising medication prematurely. Individuals in the prodrome of depression may ruminate on their depression with a further worsening of their depressive symptoms. False alarms may occur, and people may seek more hospital care or receive higher doses of medication such as antidepressants without any obvious benefit (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). </P>
<P>Recent work has indicated that the effectiveness of CBT in bipolar disorder on time to any recurrence and symptoms of depression and mania was confined to patients without numerous previous bipolar episodes (<LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> ). A large number of previous bipolar episodes has been associated with neuropsychological impairment (<LINK REF="REF-Denicoff-1999" TYPE="REFERENCE">Denicoff 1999</LINK>) and poor handling of stress (<LINK REF="REF-Hammen-1997" TYPE="REFERENCE">Hammen 1997</LINK>). However, age, gender and baseline medication did not influence the effectiveness of the EWS intervention (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). Thus, it is predicted that the effectiveness of interventions for EWS might vary according to number of previous bipolar episodes.</P>
<P>At present, the precise mechanism of action of EWS interventions in delaying recurrence in BPD remains unclear. EWS interventions appear effective in BPD patients who show good or poor adherence to medication (<LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>). Time spent with a therapist does not explain the effectiveness of EWS interventions (<LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>). EWS interventions may be effective because milder symptoms in the early stage of recurrence are easier to treat than more severe symptoms later in the recurrence. Patients report feeling more confident about returning to work and taking on other responsibilities in their lives, because EWS interventions forewarn the patient of a recurrence in time for the BPD patient to prevent any serious harm to their lives (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="REF-Morriss-2004" TYPE="REFERENCE">Morriss 2004</LINK>).<BR/>
<BR/>Previous research has indicated that family members detect early warning signs later than the person diagnosed with schizophrenia (<LINK REF="REF-Birchwood-1989" TYPE="REFERENCE">Birchwood 1989</LINK>). Given this finding and other research indicating that some EWS in bipolar disorder are likely to be subjectively perceived (for example, changes in perception of colours and noise), EWS interventions should be more effective when the person with bipolar disorder is trained to recognise early signs rather than the carer. However, inclusion of family members in training might enhance the outcome of EWS interventions because they may recognise additional EWS signs due to behaviour ( for example playing particular pieces of music), can be a point of reference if the patient wants to discuss the significance of an EWS, and can provide both practical help and emotional support. </P>
<P>There is encouraging evidence of the potential benefits of relapse prevention in serious mental illness (<LINK REF="REF-Mueser-2002" TYPE="REFERENCE">Mueser 2002</LINK>). There is no systematic review of the clinical effectiveness of the range of self-help, medication, psycho-education and psychotherapy (principally cognitive behaviour therapy and family therapy) approaches that incorporate the recognition and prompt management of early or prodromal symptoms of recurrence. The primary target of such interventions is to increase time to the next recurrence and reduce recurrence, but there may be additional benefits in terms of improving social and occupational function, quality of life, depressive symptoms and patient empowerment. There is some evidence to suggest that persons with minimal training are able to teach these skills (see <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). One implication might be that people who use services could train other service users in these potentially efficacious techniques, thus making the intervention more widely available. This review seeks to examine whether participation of caregivers in training influences the effectiveness of the intervention. The review also aims to investigate whether outcomes differ significantly if EWS represents the primary focus of the intervention or is only one of a number of techniques taught.</P>
</BACKGROUND>
<OBJECTIVES>
<P>The overall aim was to conduct a systematic review of all intervention studies that included systematically teaching the recognition of early warning signs (EWS) of recurrence to people diagnosed with bipolar disorder and/or their carers. The objectives were: </P>
<P>1. To compare the effectiveness of an EWS intervention plus treatment as usual (TAU) versus TAU not involving a psychological therapy on time to manic, depressive and all bipolar episodes.<BR/>2. To compare the effectiveness of an EWS intervention plus TAU versus TAU plus another psychological therapy on time to manic, depressive and all bipolar episodes.<BR/>3. To compare the effectiveness of intermittent medication used on recognition of EWS without continued mood stabilising medication versus TAU involving continued mood stabilising medication on time to manic, depressive and all bipolar episodes.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>
<B>Inclusion criteria<BR/>
</B>Only randomised controlled trials were included. Studies were not excluded on the basis of language, country of origin or publication status.</P>
<P>
<B>Exclusion criteria</B>
<BR/>Studies that were not randomised controlled trials were excluded. These included case series, pre and post-intervention studies and those studies with a non-random allocation from waiting list. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>
<B>Inclusion criteria</B>
<BR/>Adults with a diagnosis of bipolar disorder or associated diagnoses based on standardised psychiatric criteria (including Research Diagnostic Criteria, DSM IV, ICD-10). Adults were included at any stage of the disorder and in any treatment setting. </P>
<P>
<B>Exclusion criteria</B>
<BR/>The review excluded studies of participants where:<BR/>1. The primary diagnosis was another disorder (for example, panic, eating disorders)<BR/>2. Participants were selected on the basis of a non-psychiatric medical condition (for example, cancer, human immune deficiency syndrome)<BR/>3. People aged sixteen or under<BR/>4. People living exclusively in institutions e.g. nursing home, prisons but not excluding temporary care arrangements such as hospitalisation<BR/>5. 'At risk' populations who have not yet received a definite diagnosis of bipolar disorder. </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>
<B>Inclusion criteria</B>
<BR/>Interventions designed to systematically train people with a diagnosis of bipolar disorder to recognise early warning signs of recurrence of episodes were included. Each person in the study must have received at least one hour of training specifically in recognising and managing EWS. EWS interventions require detailed history taking, with or without additional techniques such as diary keeping and card sorting techniques, and a plan of action based on the EWS. Therefore, EWS interventions required at least one hour of face to face clinical contact. Any intervention that included EWS interventions either as a major focus or as one component of an intervention package was included. The interventions might be individually based or group based. The interventions to be included would also encompass self-help approaches. Studies involving family members or carers were also included. EWS interventions were be included if they were carried out in community, primary care or secondary care settings. </P>
<P>During abstract review, in the absence of an explicit description of early warning signs training, studies where the intervention was described as cognitive, family, psychosocial, education, self-monitoring, interpersonal, relapse prevention, self-help, problem-solving, counselling or targeted/intermittent medication were considered as potentially including EWS interventions.</P>
<P>The following comparisons were to be made:<BR/>1. To compare the effectiveness of an EWS intervention plus treatment as usual (TAU) versus TAU not involving a psychological therapy on time to manic, depressive and all bipolar episodes<BR/>2. To compare the effectiveness of an EWS intervention plus TAU versus TAU plus another psychological therapy on time to manic, depressive and all bipolar episodes<BR/>3. To compare the effectiveness of intermittent medication used on recognition of EWS without continued mood stabilising medication versus TAU involving continued mood stabilising medication on time to manic, depressive and all bipolar episodes.</P>
<P>
<B>Exclusion criteria</B>
<BR/>Studies where both groups simultaneously received the same psychological intervention involving EWS were excluded (for example, psychological therapy versus psychological therapy in addition to medication).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>
<B>Primary outcome</B>
<BR/>1. Time to first recurrence of any type. </P>
<P>
<B>Secondary outcomes</B> <BR/>1. Manic, hypomanic or mixed affective episodes and time to depressive episodes.</P>
<P>2. Percentage of people who were hospitalised. </P>
<P>3. Measures of symptoms, functioning and medication, where available at 3,6, 12, 18 and 24 months or more after baseline:<BR/>Functioning: Social functioning/interpersonal functioning, occupational functioning (e.g. MRC Social Performance Scale (<LINK REF="REF-Hurry-1983" TYPE="REFERENCE">Hurry 1983</LINK>).<BR/>Symptoms: Continuous measures of symptoms (depression on Beck Depression Inventory; BDI (<LINK REF="REF-Beck-1961" TYPE="REFERENCE">Beck 1961</LINK>); Hamilton Depression Rating Scale; HDRS (<LINK REF="REF-Hamilton-1960" TYPE="REFERENCE">Hamilton 1960</LINK>); Montgomery-Asberg Depression Rating Scale; MADRS (<LINK REF="REF-Montgomery-1979" TYPE="REFERENCE">Montgomery 1979</LINK>); Hospital Anxiety and Depression Scale; HAD (<LINK REF="REF-Zigmond-1983" TYPE="REFERENCE">Zigmond 1983</LINK>); mania on Bech Rafaelsen Mania Scale (<LINK REF="REF-Bech-1978" TYPE="REFERENCE">Bech 1978</LINK>); Young Mania Scale (<LINK REF="REF-Young-1978" TYPE="REFERENCE">Young 1978</LINK>); Longitudinal Interval Follow-up Evaluation; LIFE (<LINK REF="REF-Keller-1987" TYPE="REFERENCE">Keller 1987</LINK>); Internal States Scale (<LINK REF="REF-Bauer-1991" TYPE="REFERENCE">Bauer 1991</LINK>); Altman Mania Scale (<LINK REF="REF-Altman-1997" TYPE="REFERENCE">Altman 1997</LINK>).<BR/>Medication: mg equivalents of chlorpromazine, imipramine, diazepam, lithium, valproate, carbamazepine.</P>
<P>4. As a measure of acceptance of the intervention, satisfaction with treatment approach.</P>
<P>We also considered other outcomes that might be particularly important to consumers such as quality of life (<LINK REF="REF-EuroQol-Group-1990" TYPE="REFERENCE">EuroQol Group 1990</LINK>) and perceived control over illness (<LINK REF="REF-Lam-1997" TYPE="REFERENCE">Lam 1997</LINK>).</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>
<B>
<BR/>1. Electronic bibliographic databases</B>
<BR/>Electronic searches were undertaken using Cochrane Collaboration Depression, Anxiety and Neurosis controlled trials registers (CCDANCTR-Studies and CCDANCTR-Studies). </P>
<P>Electronic search terms were:<BR/>CCDANCTR-Studies - searched on 20/10/2005<BR/>Diagnosis = "Affective Disorder" or "Affective Psychosis, Bipolar" or "Bipolar Depression" or "Bipolar I Disorder" or "Bipolar II Disorder" or "Cyclothymic Disorder" or "Depression, Psychotic" or "Depression, Recurrent" or "Excited Psychosis" or "Major Affective Disorders" or "Mania" or "Manic Disorder" or "Bipolar Affective Disorder" or "Bipolar Not Otherwise Specified" or "Schizoaffective Disorder" or "Psychoses" or "Psychotic Disorders".<BR/>and<BR/>Intervention= "Clinical Status" or "Cognitive Behavioral Therapy" or "Cognitive Therapy" or "Consumer Advocacy" or "Consumer Led Care" or "Early Intervention" or "Education" or "Family-Focused Psychoeducational Therapy" or "Family Therapy" or "Group Therapy" or "Inpatient Family Intervention" or "Marital Therapy" or "Monitoring" or "Self-Directed Health and Social Care Use" or "Psycho education or "Psychotherapy" or "Self-Evaluation" or "Self Monitoring" or "Skills Training" or "Spouses".</P>
<P>CCDANCTR-References - searched on 20/10/2005<BR/>Keyword = Bipolar* or Mania or Manic* or Cyclothymic<BR/>and<BR/>Free-Text = "Clinical Status" or "Cognitive Behavioral Therapy" or "Cognitive Therapy" or "Consumer Advocacy" or "Consumer Led Care" or "Early Intervention" or Education or "Family-Focused Psychoeducational Therapy" or "Family Therapy" or "Group Therapy" or "Inpatient Family Intervention" or "Marital Therapy" or "Monitoring" or "Self-Directed Health and Social Care Use" or "Psychoeducation" or "Psychotherapy" or "Self-Evaluation" or "Self Monitoring" or "Skills Training " or "Spouses" or "relapse prevention" or "early warning"</P>
<P>
<B>2. Handsearches</B>
<BR/>A hand search of all issues of Bipolar Disorders was carried out</P>
<P>
<B>3. NHS National Research Register (NRR)</B>
<BR/>This was inspected for information regarding ongoing research trials.<BR/>
<B>
<BR/>4. Reference Lists<BR/>
</B>All reference lists of selected studies and relevant reviews were inspected for additional relevant titles</P>
<P>
<B>5. Personal communication</B>
<BR/>We contacted researchers who have previously published in this area</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>
<B>
<BR/>1. Decision to include or exclude study from review</B>
<BR/>
<B>
<I>
<BR/>Inspection of citations</I>
</B>
<BR/>All abstracts were independently reviewed by two out of three review authors (MAF, RM) with reference to the inclusion/exclusion criteria, and a decision was made whether to retrieve the full report of the study. The number of abstracts identified, accepted and rejected was recorded.</P>
<P>
<B>
<I>Inspection of retrieved reports</I>
</B>
<BR/>Once the full reports were retrieved, they were inspected for relevance to the review and inclusion and exclusion criteria applied. Studies not meeting the predetermined criteria were excluded. A record was made of the number of papers retrieved, the number of papers excluded and the reasons for exclusion.</P>
<P>
<B>2. Data extraction</B>
<BR/>A formal data extraction form was designed. Information regarding methods, participants, comparison groups, interventions and outcomes (noting where primary and secondary outcomes were not measured, or measured but not reported) was tabulated. Data were recorded to assess potential sources of clinical heterogeneity, including study design, participant characteristics and aspects of intervention content and delivery. All included studies were rated according to methodological quality criteria (see following section). Data extraction was performed by MF and JMcC, except for time to recurrence data, which were extracted by AJ and PW. </P>
<P>
<B>
<I>Determining whether described intervention included training in recognising and managing EWS</I>
</B>
<BR/>The essential elements of early warning signs (EWS) monitoring were defined as: <BR/>1. Education to increase awareness of EWS and identification of these EWS <BR/>2. Person with bipolar disorder learning to self-monitor for EWS (e.g. mood monitoring), or carers and/or health professionals learning to monitor on behalf of the person with bipolar disorder <BR/>3. Early action to prevent development of recurrence (e.g. early help seeking or self-coping methods).</P>
<P>Where the information was ambiguous in the original report, attempts were made to contact the corresponding author of the study, or the first or most senior author when the corresponding author was not designated. A standard letter was sent by post or e-mail requesting the authors to clarify whether the intervention included early warning signs training, and if yes, whether the intervention was systematically employed with all participants. A further letter was mailed if the author did not respond to the initial letter. If there was no response to the second mailing, the study was then excluded from any further analysis.</P>
<P>
<B>
<I>All studies were categorised by: </I>
</B>
<BR/>
</P>
<UL>
<LI>Target of intervention: 1. Interventions targeted at patient's own recognition of early warning symptoms; 2. Interventions targeted at recognition of early warning symptoms by carers or health professionals; 3. Interventions targeted at both patient and carer</LI>
<LI>Individual or group treatment</LI>
<LI>Focus of intervention: EWS was primary focus of intervention or one component of a multifaceted intervention </LI>
<LI>Intervention as an addition or replacement for treatment as usual (TAU): 1. Intervention targeting early warning symptoms plus TAU versus TAU not including psychological treatment; 2. EWS intervention plus TAU versus another psychological treatment not involving EWS plus TAU; 3. EWS intervention with intermittent medication use in presence of EWS without continued mood stabiliser medication versus TAU using continued mood stabiliser medication</LI>
<LI>EWS intervention involved only help-seeking from others, or EWS intervention involved other self-directed coping</LI>
<LI>RCT involved euthymic BPD patients or BPD patients who were in depressive episode</LI>
<LI> RCT included BPD patients with axis 1 or axis 2 psychiatric comorbidity (<LINK REF="REF-APA-1995" TYPE="REFERENCE">APA 1995</LINK>) or excluded patients with axis 1 or 2 comorbidity.</LI>
</UL>
<P>
<BR/>
<B>3. Assessing methodological quality of studies</B>
<BR/>All RCTs were assessed for methodological quality. The items assessed were allocation concealment, method of randomisation, blinding, whether an intention to treat analysis was used and attrition. Allocation concealment and the method of randomisation were rated as either clear, unclear or inadequate. When the analysis reported was not an intention to treat analysis, we contacted the authors to try to obtain the results from the intention to treat analysis. Loss to follow-up was rated as either adequate (80 per cent or more follow-up) or inadequate (less than 80 per cent follow-up). Blinding was reported as either single, double or open, and where possible, we reported who was blinded in the trial. It was not possible to explore each of these methodological factors in a meta-regression as planned in the protocol, due to the sparsity of information available in the trials. Missing data were not imputed according to a best/worse case scenario, because the primary outcome was time to event data rather than categorical data. </P>
<P>
<B>4. Methods of statistical analysis</B>
<BR/>
<B>
<I>
<BR/>Treatment outcomes<BR/>
</I>
</B>The treatment outcomes relevant to this study were measured as time to recurrence of episodes, measures of symptoms and outcomes presented as dichotomous (hospitalisation/no hospitalisation) or continuous (means and standard deviations on rating scales). </P>
<P>
<B>
<I>Choice of methods for pooling of data</I>
</B>
<BR/>Dichotomous data were summarised in terms of relative risks. Time to recurrence data were summarised in terms of log hazard ratios. Log hazard ratios and the standard errors of the log hazard ratios were entered into Review Manager software, and analysed using the generic inverse variance method. These data were extracted from the published papers using the methods described by Parmar (<LINK REF="REF-Parmar-1998" TYPE="REFERENCE">Parmar 1998</LINK>). Continuous data such as medication, symptomatology and functioning measured with standardised, published measures were summarised in terms of a difference in means, provided skewness was not too great. Continuous data were classed as being skewed if the standard deviation was over half the size of the mean (this is only true if the data can take positive values only, it does not apply to change data, for example). Skewed data were not pooled, and the results were presented in additional tables, with no statistical analyses performed on these data. Where this was the case, we contacted the study authors to obtain the change from baseline data that could be included in the analyses. Where data had been reported at a number of different time points throughout the course of a study, we reported when data had been measured within the trial, what had been reported within the published paper, and combined the data at clinically relevant intervals. Methods for the meta-analysis of continuous aggregate longitudinal data have been described (<LINK REF="REF-Jones-2005" TYPE="REFERENCE">Jones 2005</LINK>), and the method that was applied to the data in this review were analysis at independent time points, thus ignoring the correlation between the time points within an individual study.</P>
<P>
<B>
<I>Meta-analysis</I>
</B>
<BR/>We aimed to conduct three types of meta-analysis:<BR/>
</P>
<UL>
<LI>Intervention targeted at recognition of EWS plus TAU versus TAU not involving psychological treatment</LI>
<LI>Intervention targeted at recognition of EWS plus TAU versus another psychological control therapy plus TAU</LI>
<LI>Intervention targeted at recognition of EWS coupled with intermittent medication use without continued mood stabilising medication versus TAU using continued mood stabilising medication. </LI>
</UL>
<P>
<BR/>Once the results of each study were summarised using an effects measure, an average value of the effect was computed across studies using either a 'fixed effect' model, if there was little heterogeneity, or a 'random effects' model when there was unexplained heterogeneity.</P>
<P>
<B>
<I>Heterogeneity</I>
</B> <BR/>If clinical heterogeneity was too great, or methodological quality too poor, studies were not pooled in a meta-analysis. A chi-squared test for heterogeneity was undertaken, and the I-squared statistic was calculated. If statistical heterogeneity was indicated (p&lt;0.1), then attempts were made to further investigate potentially influential study characteristics via meta-regression. Random effects modelling was employed where significant residual heterogeneity existed. A distinction was made between quantitative and qualitative heterogeneity.<BR/>
<BR/>It was acknowledged that certain subgroup analyses might not be possible due to limited number of studies or insufficient information available. Where this occurred, a qualitative review of information was completed if possible. The following subgroup analyses were planned:</P>
<UL>
<LI>depressed episode (presence or absence) at baseline</LI>
<LI>axis 1 or axis 2 comorbidity (presence or absence) at baseline</LI>
<LI>EWS as primary focus of the intervention or as part of another intervention</LI>
<LI>EWS intervention delivered to patient only or patient and carer or health professional</LI>
<LI>EWS intervention delivered to carer only versus carer and patient</LI>
<LI>EWS intervention delivered individually versus group intervention</LI>
<LI>EWS intervention promotes only help seeking from others versus additional self-directed coping. </LI>
</UL>
<P>
<BR/>
<B>
<I>Publication bias </I>
</B>
<BR/>Publication bias was assessed by visual inspection of funnel plots. Consideration was given to within-study selective reporting bias (<LINK REF="REF-Hahn-2000" TYPE="REFERENCE">Hahn 2000</LINK>; <LINK REF="REF-Williamson-2005" TYPE="REFERENCE">Williamson 2005</LINK>).</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>Electronic searches of the CCDAN Controlled Trials Register were conducted to identify relevant studies. Thirty-five studies were relevant, based on the abstracts. These papers were obtained and scrutinised by two review authors (RM and MF). Eight of these met our inclusion criteria. Hand searching of the Bipolar Disorders journal revealed four relevant abstracts, of which only one met our inclusion criteria when the full paper was obtained (<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>, included under Ongoing studies). None were included from the reference list of other included studies. Two other papers were included after reviewing the original paper when they were published (<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). In total, eleven studies met our inclusion criteria. One of the studies was reported twice (<LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>) and another was reported three times (<LINK REF="REF-Simoneau-1999" TYPE="REFERENCE">Simoneau 1999</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>; <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>). One was an ongoing study (<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>). There is an additional ongoing study that is likely to be relevant to the review, but at present we do not have data (<LINK REF="REF-Ball-2003" TYPE="REFERENCE">Ball 2003</LINK>).</P>
<P>
<B>1. Excluded studies</B>
<BR/>Please refer to Table of Excluded Studies for details of individual trials.</P>
<P>
<B>2. Ongoing trials</B>
<BR/>One study (<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>) was presented as a conference proceeding, and the author supplied us with the first three months follow-up results. The author was contacted for further results, but we did not receive any further data. We have contacted the author of another study which has published its methodology (<LINK REF="REF-Ball-2003" TYPE="REFERENCE">Ball 2003</LINK>), but we have not received any data from that study.</P>
<P>
<B>3. Included studies</B>
<BR/>Three studies were duplicate reports (<LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="REF-Simoneau-1999" TYPE="REFERENCE">Simoneau 1999</LINK> , <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>) and 11 studies (of which one was ongoing) met our inclusion criteria. The studies are described in the Table of Included Studies. </P>
<P>
<B>
<I>3.1 Methods</I>
</B>
<BR/>All trials were RCTs, but none were able to use a double blind technique due to difficulties in blinding psychosocial interventions. All studies tried to reduce bias by using independent outcome assessors, except three trials where blinding of the assessors was not mentioned (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>) . The duration of follow-up ranged from 12 months to 24 months, except one trial where participants were followed up for only six months (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>).</P>
<P>
<B>
<I>3.2 Participants</I>
</B>
<BR/>All trials included people with a diagnosis of bipolar disorder, aged &gt;18 years. All employed operational criteria for diagnosis ( DSM-111-R, DSM-IV). Most of the trials used structured assessment (SCID, SADS) to arrive at the diagnosis, except two trials which used the opinion of senior psychiatrists (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK> ), one study did not specify anything (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>), and another trial used the opinion of two independent psychiatrists (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>). Axis 1 and axis 2 psychiatric comorbidity were included in eight of the trials (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>(a); <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>;<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>; <LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>). Other trials excluded axis 1 and axis 2 psychiatric morbidity or did not state whether these morbidities were included or excluded. </P>
<P>
<B>
<I>3.3 Interventions</I>
</B>
<BR/>In all studies, treatment as usual (TAU) included treatment with medication and outpatient appointments with a psychiatrist. In two trials (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>), TAU was supplemented by 20 sessions of non-structured group meetings. In all studies, EWS interventions provided education to the patient about the nature of bipolar disorder, as well as early warning sign recognition and management, in addition to TAU. The interventions ranged from five sessions (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>) to 221 sessions (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>). The interventions for managing EWS, once recognised by the patient, ranged from complex individual approaches such as cognitive therapy (e.g. <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>, <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) to simple individual approaches that involved seeking an urgent appointment with health professionals (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>), and also group and family focused psychoeducation (e.g. <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>). There were no studies utilising EWS interventions with intermittent medication. </P>
<P>
<B>
<I>3.4 Outcomes</I>
</B>
</P>
<P>
<I>3.4.1 Time to any relapse</I>
<BR/>Six trials reported time to any relapse ( <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) . </P>
<P>
<I>3.4.2 Time to manic/hypomanic or depressive episode</I>
<BR/>Time to manic/hypomanic or depressive episode were reported by four trials (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) . Another four trials reported time to depressive episode (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) . One trial reported mixed recurrence (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>). Some trials (<LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>; <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>) reported outcomes that could not be used due to incomplete information. </P>
<P>
<I>3.4.2 Percentage of people hospitalised</I>
<BR/>These were reported in four of the trials (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>). <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK> reported that mean number of hospitalisations was not significant when adjusted, but did not provide the number of people admitted. Two trials reported on hospitalisation, but did not specify the number of people in control and intervention groups who were hospitalised (<LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>), and hence the data could not be analysed. Number of days spent in hospital was recorded by two trials (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>).</P>
<P>
<I>3.4.3 Depressive symptoms</I>
<BR/>
<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK> and <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK> reported on depressive symptoms measured by the Beck Depression Inventory (BDI) and Hamilton Depression Rating Scale (HDRS). Authors of <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK> and <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> supplied us with HDRS scores and <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> supplied BDI scores. Data on BDI and HDRS could not be extracted from <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>, because they were incomplete.</P>
<P>
<I>3.4.4 Manic symptoms</I>
<BR/>Authors of <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK> and <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> provided Bech Rafaelsen Mania Scale (BRMS) scores.</P>
<P>
<I>3.4.5 Measure of functioning</I>
<BR/>Two trials reported on social functioning measured by MRC social performance scale (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>reported functioning by Global Assessment of Function (GAF) and Work and Social Adjustment Scale (WASA) scores, but these could not be translated into scores on the MRC social performance scale.</P>
<P>Secondary outcomes of satisfaction with the intervention, quality of life and perceived control over illness, that were outlined in the protocol, could not be analysed due to the absence of complete information in the original reports.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>For further information please refer to additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> 'Methodological quality of included studies'.</P>
<P>All trials included were randomised controlled trials. Three trials did not report the method of randomisation (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>; <LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>). Blinding was not easy due to the nature of interventions, and most of the trials had independent outcome assessors, with the exception of three trials (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>). None of the trials reported prospective rating of blinding, except one trial (<LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>) in which it was reported that it proved difficult to keep assessors unaware of the patients' psychosocial group assignments. It was stated in nine trials that an intention to treat analysis (ITT) was undertaken. Two trials did not state whether an ITT analysis had been performed (<LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>;<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>).</P>
<P>Six studies were scored as category A (Adequate) for concealment of allocation, four of the studies (<LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>; <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>) were scored as category B (Unclear), and an ongoing study (<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>) was also scored as B. Please refer to additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> for details on individual trials. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>
<B>1. The search</B>
<BR/>Out of the 11 included studies, only six studies reported the primary outcomes outlined in the protocol for this review (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). One trial reported only secondary outcomes outlined in the protocol (<LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>). Three of the studies did not report any outcomes that could be used (<LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>;<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>;<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>).</P>
<P>
<B>2. Primary outcomes</B> (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>)</P>
<P>
<B>
<I>2.1 Time to first recurrence of any type </I>
</B>
<BR/>Data were available from six trials. The pooled estimate was significant favouring the EWS intervention group (random effects, hazards ratio 0.57, 95% CI 0.39 to 0.82), but the results showed heterogeneity (chi<SUP>2 </SUP>=16.23, df =5, p=0.006, I-squared = 69.2%). <BR/>
<B>
<I>
<BR/>2.2 Time to manic/hypomanic episode</I>
</B>
<BR/>Data were available from four trials. The pooled estimate was almost significant favouring the EWS intervention group (random effects, hazards ratio 0.66, 95% CI 0.40 to 1.06), but the results showed heterogeneity (chi<SUP>2</SUP>=9.29, df =3, p=0.03, I-squared = 67.7%).</P>
<P>
<B>
<I>2.3 Time to depressive episode</I>
</B>
<BR/>Data were available from four trials. The pooled estimate was significant favouring the EWS intervention group (random effects, hazards ratio 0.57, 95% CI 0.33 to 0.99), but the results showed heterogeneity (chi<SUP>2</SUP> =11.97, df =3, p=0.007, I-squared =74.9%).</P>
<P>
<B>3. Secondary outcomes </B>(<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>)</P>
<P>
<B>
<I>3.1 Percentage of people hospitalised</I>
</B>
<BR/>Four trials reported this outcome (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>). The pooled estimate was significant favouring the EWS intervention group (fixed effect, RR 0.67, 95% CI 0.47 to 0.95), and the results showed little heterogeneity (chi<SUP>2</SUP>=3.03, df =3, p =0.39, I-squared=1.0%). We intended to do a best/worse case scenario, but there was only one missing set of data values (one of the participants died), and the best/worse case scenario did not make any significant difference to the conclusions.</P>
<P>
<B>
<I>3.2 Measure of depressive symptoms </I>
</B>
<BR/>
<BR/>
<I>3.2.1 BDI Scale<BR/>
</I>Post measurement data were obtained from two studies (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). The data showed characteristics of being skewed and were therefore not entered into a meta-analysis. The data (means and standard deviations for each treatment groups) were entered into an additional table (<LINK REF="TBL-19" TYPE="TABLE">Table 19</LINK>), and no formal statistical analyses were applied. For the next issue of the review, we intend to contact the authors of the studies to obtain data on change from baseline for each of the groups.<BR/>
<BR/>
<I>3.2.2 HDRS scale<BR/>
</I>Post measurement data were obtained from three studies (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>;<LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). The data showed characteristics of being skewed, and therefore were not entered into a meta-analysis. The data (means and standard deviations for each treatment groups) were entered into an additional table (<LINK REF="TBL-20" TYPE="TABLE">Table 20</LINK>), and no formal statistical analyses were applied. For the next issue of the review, we intend to contact the authors of the studies to obtain data on change from baseline for each of the groups.<BR/>
<BR/>
<I>3.2.3 BRMS<BR/>
</I>Post measurement data were obtained from two studies (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). The data showed characteristics of being skewed, and therefore were not entered into a meta-analysis. The data (means and standard deviations for each treatment groups) were entered into an additional table (<LINK REF="TBL-21" TYPE="TABLE">Table 21</LINK>), and no formal statistical analyses were applied. For the next issue of the review, we intend to contact the authors of the studies to obtain data on change from baseline for each of the groups.</P>
<P>
<I>3.3.1 MRC Social Performance<BR/>
</I>This was reported by two studies (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). Post measurement data were obtained from one study (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>). The data showed characteristics of being skewed and therefore were not entered into a meta-analysis. The data (means and standard deviations for each treatment groups) were entered into an additional table (<LINK REF="TBL-22" TYPE="TABLE">Table 22</LINK>), and no formal statistical analyses were applied. For the next issue of the review we intend to contact the authors of the study to obtain data on change from baseline for each of the groups. Change from baseline data was reported by one study (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>) at three time points (6 months, 12 months and 18 months). There was no statistical difference in scores between the two treatment groups at 6 and 12 months, but a statistical difference was reported between the two groups at 18 months.</P>
<P>
<B>4. Heterogeneity</B>
<BR/>We examined heterogeneity at various levels in those studies that contributed primary outcome data on time to first bipolar episode. </P>
<P>
<B>
<I>4.1 Comparison of studies that included psychological component without EWS in TAU and those that had only TAU in control groups </I>
</B>
<BR/>Four of the trials included TAU alone for the control group (<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>; <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>). Two studies included psychological intervention that did not include EWS component along with TAU (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>) to control for the non-specific effects of psychological treatment, including time spent with therapists.</P>
<P>The sub-group analysis for time to any recurrence can be seen in Figure 02 02, and the results are presented in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>. The meta-regression analysis showed no significant difference for this factor (<LINK REF="TBL-18" TYPE="TABLE">Table 18</LINK>).<B>
<BR/>
</B>
<BR/>Time to manic/hypomanic episode (<LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>) was reported by three of the above non-psychological TAU trials ( <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> ) and one of the non-EWS psychological group TAU trials (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>). The sub-group analysis can be seen in Figure 02 02. A meta-regression was not carried out for this factor, due to the lack of information in a number of studies. <B>
<BR/>
</B> <BR/>Time to depressive episode (<LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>) was reported by three non-psychological TAU studies (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>) and one of the psychological TAU studies (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>). The sub-group analysis can be seen in Figure 02 03. A meta-regression was not carried out for this factor, due to the lack of information in a number of studies.</P>
<P>
<B>
<I>4.2 Time to first recurrence of any type for TAU vs enhanced TAU in control group </I>
</B>
<BR/>In Graph 02 01, we compared time to first recurrence of any type for psychological +TAU Vs non psychological +TAU (section 4.1). Three of the non-psychological TAU trials (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) used only TAU ,but one of the trials (<LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>) used enhanced TAU with two additional sessions to provide education about bipolar disorder in the community, as well as the non-psychological TAU delivered to patients with bipolar disorder as part of routine care . The sub-group analysis can be seen in Figure 02 04. A meta-regression was not carried out for this factor due to the lack of information in a number of studies.</P>
<P>
<B>
<I>4.3 Time to first recurrence of any type for Intervention delivered in groups vs individually </I>
</B>(<LINK REF="TBL-10" TYPE="TABLE">Table 10</LINK>)<BR/>Three trials delivered the intervention in groups (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>) and other three delivered it individually (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). The results from the sub-group analysis can be seen in Figure 02 05. The meta-regression analysis showed no significant difference for this factor (<LINK REF="TBL-18" TYPE="TABLE">Table 18</LINK>).There were insufficient data to compare time to manic/hypomanic and depressive episodes. </P>
<P>
<B>
<I>4.4 Time to any recurrence for patients stabilised for at least one month after last acute bipolar episode vs patients recruited during or immediately after (&lt; one month) acute bipolar episode </I>
</B>(<LINK REF="TBL-11" TYPE="TABLE">Table 11</LINK>)<BR/>One of the studies (<LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) recruited patients in an acute bipolar episode and another (<LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>) included patients immediately after an acute bipolar episode. The sub-group analysis can be seen in Figure 02 06. The meta-regression analysis showed no significant difference for this factor (<LINK REF="TBL-18" TYPE="TABLE">Table 18</LINK>). Heterogeneity was abolished, and EWS interventions were effective in reducing time to the next bipolar episode in trials confined to patients recruited at least one month after remission from an acute bipolar episode. There were insufficient data to explore the effects on manic/hypomanic episode or depressive episodes.</P>
<P>
<B>
<I>4.5 Simple vs complex interventions for EWS</I>
</B>
<BR/>One study examined only the recognition of EWS and seeking help early from health professionals (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>). The other five studies (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>) provided the patient and/or family with more complex plans of management for EWS once they were recognised, plus additional help for managing bipolar disorder. The results for time to first recurrence of any type are shown in <LINK REF="TBL-12" TYPE="TABLE">Table 12</LINK> and the sub-group analysis can be seen in Figure 02 07. </P>
<P>There was an insufficient number of studies in one of the sub-groups to perform a meta-regression. <B>
<BR/>
</B>
<BR/>Time to manic/hypomanic episode results are reported in <LINK REF="TBL-13" TYPE="TABLE">Table 13</LINK> and time to depressive episode are shown in <LINK REF="TBL-14" TYPE="TABLE">Table 14</LINK>. The sub-group analyses can be seen in Figures 02 08 and 02 09 respectively. There was an insufficient number of studies in one of the sub-groups to perform a meta-regression. <BR/>
<BR/>
<B>
<I>4.6 EWS interventions where the primary focus is EWS versus interventions where EWS is not the primary focus of the intervention</I>
</B>
<BR/>Five studies were judged to have a primary focus on EWS interventions on the basis of the time devoted to the EWS interventions, the teaching of the EWS intervention early in the treatment and/or the emphasis given to the intervention in the authors' description of the intervention (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>; Perry 1999). Only one study was judged to include EWS, but not as the primary focus of the intervention (<LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>). </P>
<P>The results for the time to first recurrence of any type can be seen in <LINK REF="TBL-15" TYPE="TABLE">Table 15</LINK> and in Figure 02 10. There was an insufficient number of studies in one of the sub-groups to perform a meta-regression. </P>
<P>The results for time to manic/hypomanic episode and time to depressive episode can be seen in <LINK REF="TBL-16" TYPE="TABLE">Table 16</LINK> and <LINK REF="TBL-17" TYPE="TABLE">Table 17</LINK>, and the sub-group analyses can be in Figures 02 11 and 02 12. For both analyses there was an insufficient number of studies in one of the sub-groups to perform a meta-regression.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>There were clinically important findings from the meta-analysis, namely that time to first relapse of any type, time to manic/hypomanic episode and time to depressive episode favoured the EWS intervention group. Two other clinically relevant findings were the percentage of people hospitalised and measure of functioning, which also favoured the EWS intervention group. However the data on functioning were sparse, based on one relatively small RCT, and only favoured the EWS intervention group at 18 months. In the protocol we had aimed to look at the effectiveness of intermittent medication used on recognition of EWS but there were no studies which satisfied our inclusion criteria. Measures of depressive and hypomanic symptoms did not show any effects of EWS interventions, suggesting that the effects on function may not be related to reducing symptoms that remain between acute bipolar episodes. Treatment that has an impact on depressive and manic type symptoms between acute bipolar episodes are highly desirable, given that people with bipolar disorder have these symptoms between 30-50 per cent of the time (<LINK REF="REF-Judd-2002" TYPE="REFERENCE">Judd 2002</LINK>). Most of the participants in this analysis had a diagnosis of Bipolar I, and there were very few with Bipolar II diagnosis. The results of this analysis may not apply to Bipolar II patients.</P>
<P>Some of the pooled estimates showed substantial heterogeneity . However, the forest plots show that they are quantitative rather than qualitative, with the direction of effect favouring the EWS intervention group. A consistency in the results favouring EWS interventions, despite variation in trial characteristics, may be used to support the view that the results are generalisable to a variety of clinical settings. Factors that may have influenced the heterogeneity were considered and examined (see under <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> , <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> , <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK> , <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> and forest plots under heterogeneity ). The most important factor in terms of investigating heterogeneity was the recruitment in some studies of patients in acute bipolar episode or shortly after the onset of the episode (<LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>). These studies differed from the others, both in patient characteristics and the delivery of the EWS intervention. <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> employed an intervention where the EWS intervention was not the primary focus of the intervention, while <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK> delivered the intervention through family psychoeducation rather than through targeting the individual. <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> provided evidence that the number of previous episodes had a bearing on the effectiveness of the psychological intervention involving EWS, with a large number of previous bipolar episodes being associated with increased bipolar recurrence and a smaller number of previous bipolar episodes being associated with decreased bipolar recurrence with the psychological intervention. A reanalysis of data from <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>, reported in <LINK REF="REF-Scott-2006a" TYPE="REFERENCE">Scott 2006a</LINK>, also confirms that psychoeducation was not effective in patients with more than 12 previous bipolar episodes. However, the patients in <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> also included those in acute bipolar episode or on immediate remission from an acute bipolar disorder, while a large proportion had other features generally regarded as having an adverse effect on outcome such as convictions or cautions for violence. </P>
<P>A meta-regression for all potential effect modifiers could not be performed due to small number of included studies. Meta-regression for two of the potential effect modifiers was performed. These were (1) the nature of the control group (non-psychological treatment as usual) versus psychological intervention control group and (2) recruited one month or more after episode versus recruited during and soon after episode. The nature of the control group did not explain the heterogeneity, but recruitment of patients during an acute bipolar episode did seem to explain the high degree of heterogeneity in the results. However, there were only a small number of studies included in the analysis. A funnel plot was done to look at publication bias. No conclusions could be made from the funnel plot, due to the small number of studies.</P>
<P>A thorough search strategy was used in this review, which included hand searching of relevant journals. There may still be gaps in the search strategy such as unpublished data (grey literature), which are difficult to get hold of. We included studies where we were confident that an EWS intervention had been attempted. Some trials did not give precise descriptions of the nature of the psychological intervention tested and we did not get a response when we wrote to some authors for clarification. All trials were randomised controlled trials (RCTs), and concealment of allocation was rated as A or B (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) . Three studies (<LINK REF="STD-Meyer-2003" TYPE="STUDY">Meyer 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>) did not report intention to treat analysis. Two studies reported using intention to treat principles (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>), but there were missing data that were not accounted for in the final reported outcomes. In all included RCTs, outcomes were not blinded, but were independently and systematically obtained with less than 20 per cent missing data . The follow up period in most trials varied from 12 to 24 months, except one trial (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK> ) in which participants were followed up for six months. All trials included personality disorder, with the exception of one trial (<LINK REF="REF-Lam-2003" TYPE="REFERENCE">Lam 2003</LINK>), and it was not clear in one other trial (<LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>). Axis 1 co-morbidity was included in two of the trials (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> ). Outcome assessments were reported as independent but not blind in all trials except <LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>. Allocation concealment was adequate for all except two trials (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="REF-Miklowitz-2000" TYPE="REFERENCE">Miklowitz 2000</LINK>) providing data for analysis. Some of the studies reported the percentage of people with personality disorders (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK> (a); <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK> ), substance abuse or dependence (<LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>), but no conclusions could be drawn concerning the effectiveness of EWS interventions in personality disorder and substance use disorders, because few trials reported outcomes in these patient groups, and individual patient data were not available.</P>
<P>A matter of concern in relation to the robustness of our findings is that five out of 11 RCTs provided no primary outcome data, possibly because they did not find a positive outcome, and introducing bias due to selective reporting of outcome measures ( <LINK REF="REF-Williamson-2005-a" TYPE="REFERENCE">Williamson 2005 a</LINK>; <LINK REF="REF-Hutton-2000" TYPE="REFERENCE">Hutton 2000</LINK>). We were unsuccessful in extracting further information on time to relapse on contacting the authors of the other RCTs. These five studies account for 43% (534/1230) of the total number of people randomised, and one trial included 441 participants (<LINK REF="STD-Simon-2004" TYPE="STUDY">Simon 2004</LINK>). If the data on the primary outcome were available from these studies (two of these studies were pilot studies for larger RCTs that contained data on the primary outcome (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>;<LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>), then it may be possible that the overall conclusion would be closer to showing no difference between the two interventions. Therefore, the results of the analyses need to be interpreted with caution. </P>
<P>The meta-analysis included a substantial number of patients. Time to first recurrence of any type included data from six studies and 690 participants. Time to manic/hypomanic episode included data from four studies and 533 participants. Time to depressive episode had data from four studies and 533 participants. Meta-analysis of percentage of people hospitalised included data from four studies and 679 participants. Less confidence should be placed in the results of EWS interventions on function. The measure of function had data from two studies and 92 participants. The data on hospitalisation comes from four studies involving 679 patients. However, a study with negative clinical outcomes did not provide data on hospitalisation, so again, caution should be applied to this result. The pooled analysis shows clearly for the first time that EWS interventions may reduce the percentage of patients who become hospitalised with an acute bipolar episode. This result may be important because hospitalisation is unpopular with most patients, in short supply and expensive. The savings made from hospitalisation might be used to fund the provision of EWS interventions that are popular with patients, provided they are targeted at patients with bipolar disorder who have a history of hospitalisation. </P>
<P>Unfortunately few trials reported on the secondary outcomes that we planned to look at, and as with the primary outcome, the results of these analyses should be interpreted with caution, due to the possibility of outcome reporting bias. For measures of function, only one trial presented results that could be used in a meta-analysis. Multiple scales were used for the same outcome, and there is no agreement currently on how comparisons can be made between these scales for people suffering from bipolar disorder. Although we aimed to look at outcomes such as measures of satisfaction with the intervention, patient empowerment and quality of life, none of the trials reported on these outcomes. There was inconsistency on how medication use were reported, and hence a meta-analysis was not attempted. </P>
<P>In the RCTs reporting the primary outcome, the EWS intervention was delivered to participants only, except in <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK> where the carer was also included. The EWS intervention was delivered in groups (<LINK REF="STD-Colom-2003c" TYPE="STUDY">Colom 2003c</LINK>; <LINK REF="STD-Colom-2003b" TYPE="STUDY">Colom 2003b</LINK>; <LINK REF="STD-Miklowitz-2003" TYPE="STUDY">Miklowitz 2003</LINK>) and individually (<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>; <LINK REF="STD-Scott-2006" TYPE="STUDY">Scott 2006</LINK>) over 12 sessions or more, except for one trial (<LINK REF="STD-Van-Gent-1991" TYPE="STUDY">Van Gent 1991</LINK>). <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK> was the only trial that used therapists with little previous experience to deliver the intervention. Therefore, successful EWS interventions seem to require around 12 sessions of therapist time and involve therapists of high competency. On this basis, EWS interventions for bipolar disorder may be expensive, although there appears to be a cost offset from reduced hospitalisation and improvements in social function, including patients returning to work. The one EWS intervention that used a less experienced and, therefore, less expensive therapist only showed a benefit against manic type recurrences and function, without any effect against depressive type recurrence. The relative cost-effectiveness of interventions involving more experienced versus less experienced therapists is a topic for further research. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Though data were obtained from a limited number of relevant trials, the results suggests psychological interventions incorporating EWS may be clinically effective in reducing relapse and hospitalisation, and possibly on function. EWS interventions had no impact on depressive and manic symptoms. The meta-analysis revealed an effect of EWS interventions on hospitalisation that was not previously well established. However, nearly half the identified RCTs did not report the primary outcome measure, so there may be a problem with selective reporting against negative outcomes. In general these trials had interventions delivered by therapists with some experience of both psychological intervention and bipolar disorder. An average of about twelve sessions of an hour long duration was used. The only exception to this was <LINK REF="STD-Perry-1999" TYPE="STUDY">Perry 1999</LINK>, which used a therapist with little previous experience. </P>
<P>Most health services in most countries could not accommodate EWS interventions within their usual treatment plans because of the way services are constructed currently and/or a shortage of staff trained to deliver EWS interventions. However, when psychological interventions for bipolar disorder can be purchased, the evidence in the meta-analysis favours interventions that incorporate the assessment and management of EWS. The cost offset of the EWS interventions through their effectiveness on both hospitalisation and social function including work could mean that EWS interventions for bipolar disorder may be cost effective and worth purchasing. The means by which EWS interventions could be efficiently delivered within existing health service systems is not clearly established.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Research into psychological interventions targeted at preventing recurrence should measure and report time to all bipolar recurrence, time to manic and depressive type recurrences, because these are the target of the intervention, and therefore should be reported as the primary outcome variables. The optimal service delivery of EWS interventions for bipolar disorder in terms of clinical and cost effectiveness and acceptability to service users requires exploration in research. At present, people with bipolar disorder tend to access many different types of service rather than services dedicated to bipolar disorder. EWS interventions may be effective for other patient groups as well; if so, then service delivery of EWS interventions might be efficiently targeted at a wide group of patients, and are more likely to become part of routine care. Another area that needs attention in future research is whether EWS interventions can be usefully applied to patients with bipolar disorder who have had many previous bipolar episodes or those who have just recently remitted from an acute bipolar episode. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We wish to acknowledge the contribution of the CCDAN editorial base in helping to devise the protocol and in particular the search strategy. We also wish to acknowledge Mersey Care NHS Trust who provided the funding that supported the systematic review and Professor Max Marshall who provided helpful advice at the outset on the design of the systematic review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>One author (RM) is the co-author for two studies that were included in the review. </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Catherine Bolton wrote first draft of protocol with Richard Morriss <BR/>and liaised with CCDAN concerning search strategy.</P>
<P>Richard Morriss originated the idea for the review and wrote first <BR/>and revised draft of protocol and the review. Richard Morriss rated studies for inclusion and extracted data.</P>
<P>Jim McCarthy conducted first search, helped devise the protocol and <BR/>commented on each draft.</P>
<P>Ashley Jones extracted primary outcome data, provided statistical expertise and commented on draft of the review.</P>
<P>Paula Williamson adjudicated data extraction, provided statistical expertise and commented on draft of the review.</P>
<P>Mohammad Faizal conducted handsearch, rated studies for inclusion, extracted secondary outcome data, conducted analysis and wrote the review with Richard Morriss.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Colom-2003b" NAME="Colom 2003b" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Colom F, Vieta E, Reinares M, Martinez-Aran A, Torrent C, Goikolea JM et al</AU>
<TI>Psychoeducation efficacy in Bipolar disorders : Beyond compliance enhancement</TI>
<SO>Journal of clinical psychiatry</SO>
<YR>2003</YR>
<VL>64</VL>
<NO>9</NO>
<PG>1101-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colom-2003c" NAME="Colom 2003c" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A et al</AU>
<TI>A randomised trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in Bipolar patients whose disease is in remission</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2003</YR>
<VL>60</VL>
<PG>402-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2000" NAME="Lam 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lam DH, Bright J, Jones S, Hayward P, Schuck N, Chisholm D et al</AU>
<TI>Cognitive therapy for Bipolar Illness - A pilot study of relapse prevention</TI>
<SO>Cognitive Therapy and Research</SO>
<YR>2000</YR>
<VL>24</VL>
<NO>5</NO>
<PG>503-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2005" NAME="Lam 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lam DH, Hayward P, Watkins ER, Wright K, Sham P</AU>
<TI>Relapse prevention in patients with bipolar disorder: Cognitive therapy outcome after 2 years</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>162</VL>
<PG>324-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lam DH, Watkins ER, Wright K, Kerr N, Parr-Davis G, Sham P</AU>
<TI>A randomised controlled study of cognitive therapy for relapse prevention for bipolar disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2003</YR>
<VL>60</VL>
<PG>145-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2003a" NAME="Meyer 2003a" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer TD, Hautzinger M</AU>
<TI>A randomised controlled trial of cognitive behaviour therapy and supportive therapy for bipolar disorders</TI>
<SO>Bipolar Disorders</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>1</NO>
<PG>135</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miklowitz-2003" NAME="Miklowitz 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miklowitz DJ , Simoneau TL , George JA , Richards JA, Kalbag A, Sachs-Ericsson N et al</AU>
<TI>Family-focused treatment of Bipolar disorder : 1-year effects of a psychoeducational program in conjunction with pharmacotherapy</TI>
<SO>Biological Psychiatry</SO>
<YR>2000</YR>
<VL>48</VL>
<PG>582-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL</AU>
<TI>A randomised study of family -focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2003</YR>
<VL>60</VL>
<PG>904-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simoneau TL, Miklowitz DJ , Richards JA, Saleem R, George EL</AU>
<TI>Bipolar Disorder and family communication : Effects of a psychoeducational treatment program</TI>
<SO>Journal of Abnormal Psychology</SO>
<YR>1999</YR>
<VL>108</VL>
<NO>4</NO>
<PG>588-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perry-1999" NAME="Perry 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Perry A, Tarrier N, Morriss R, McCarthy E, Limb K</AU>
<TI>Randomised controlled trial of efficacy of teaching patients with Bipolar disorder to identify early symptoms of relapse and obtain treatment</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>318</VL>
<PG>149-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-2001" NAME="Scott 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scott J, Garland A, Moorhead S</AU>
<TI>A pilot study of cognitive therapy for bipolar disorders</TI>
<SO>International Journal of Neuropsychopharmacology</SO>
<YR>2000</YR>
<VL>3</VL>
<NO>1</NO>
<PG>10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scott J, Garland A, Moorhead S</AU>
<TI>A pilot study of cognitive therapy in bipolar disorders</TI>
<SO>Psychological Medicine</SO>
<YR>2001</YR>
<VL>31</VL>
<PG>459-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-2006" NAME="Scott 2006" YEAR="2006">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T et al</AU>
<TI>Cognitive behaviour therapy for severe and recurrent Bipolar disorders: a randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>188</VL>
<PG>313-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2004" NAME="Simon 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Simon GE, Ludman EJ, Unutzer J, Bauer MS, Operskalski B, Rutter C</AU>
<TI>Randomised trial of a population-based care program for people with bipolar disorder</TI>
<SO>Psychological Medicine</SO>
<YR>2004</YR>
<VL>34</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Gent-1991" NAME="Van Gent 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van Gent EM, Zwart FM</AU>
<TI>Psychoeducation of partners of Bipolar-manic patients</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1991</YR>
<VL>21</VL>
<PG>15-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Beardslee-1992" NAME="Beardslee 1992" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Beardslee W, Hoke L, Wheelock I, Rothberg P, Van De Velde P, Swatling S</AU>
<TI>Initial findings on preventive intervention for families with parental affective disorders</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1992</YR>
<VL>149</VL>
<NO>10</NO>
<PG>1335-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beardslee-1993" NAME="Beardslee 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Beardslee WR, Salt P, Porterfield K, Rothberg PC, van de Velde P, Swatling S et al</AU>
<TI>Comparison of preventive interventions for families with parental affective disorder</TI>
<SO>Journal of the American Academy of Child and Adolescent Psychiatry</SO>
<YR>1993</YR>
<VL>32</VL>
<NO>2</NO>
<PG>254-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becker-1998" NAME="Becker 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Becker DR, Drake RE, Bond GR, Xie H, Dain BJ, Harrison K</AU>
<TI>Job terminations among persons with severe mental illness participating in supported employment</TI>
<SO>Community Mental Health Journal</SO>
<YR>1998</YR>
<VL>34</VL>
<NO>1</NO>
<PG>71-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-1994" NAME="Burns 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Burns DD, Sayers SL, Moras K</AU>
<TI>Intimate relationships and depression : Is there a causal connection</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1994</YR>
<VL>62</VL>
<NO>5</NO>
<PG>1033-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clarkin-1998" NAME="Clarkin 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Clarkin JF, Carpenter D, Hull J, Wilner P, Glick I</AU>
<TI>Effects of psychoeducational intervention for married patients with Bipolar disorder and their spouses</TI>
<SO>Psychiatric Services</SO>
<YR>1998</YR>
<VL>49</VL>
<PG>531-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cochran-1984" NAME="Cochran 1984" YEAR="1984">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cochran SD</AU>
<TI>Preventing medical noncompliance in the outpatient treatment of Bipolar affective disorders</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1984</YR>
<VL>52</VL>
<NO>5</NO>
<PG>873-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Draine-1994" NAME="Draine 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Draine J, Solomon P</AU>
<TI>Explaining attitudes toward medication compliance among seriously mentally ill population</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1994</YR>
<VL>182</VL>
<NO>1</NO>
<PG>50-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drake-1996" NAME="Drake 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Drake RE, McHugo GJ, Becker DR, Anthony WA, Clarke RE</AU>
<TI>The New Hampshire study of supported employement for people with severe mental illness</TI>
<SO>Journal of consulting and clinical psychology</SO>
<YR>1996</YR>
<VL>64</VL>
<NO>2</NO>
<PG>391-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elixhauser-1990" NAME="Elixhauser 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Elixhauser A, Eisen SA, Romeis JC, Homan SM</AU>
<TI>The effects of monitoring and feedback on compliance</TI>
<SO>Medical Care</SO>
<YR>1990</YR>
<VL>28</VL>
<NO>10</NO>
<PG>882-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frank-2005" NAME="Frank 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM et al</AU>
<TI>Two-Year Outcomes for Interpersonal and Social Rhythm Therapy in Individuals With Bipolar I Disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2005</YR>
<VL>62</VL>
<PG>996-1004</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glick-1993" NAME="Glick 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Glick ID, Clarkin JF, Haas GL, Spencer JH</AU>
<TI>Clinical significance of inpatient family intervention: conclusions from a clinical trial</TI>
<SO>Hospital and Community Psychiatry</SO>
<YR>1993</YR>
<VL>44</VL>
<NO>9</NO>
<PG>869-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Honig-1997" NAME="Honig 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Honig A, Hofman A, Rozendaal N, Dingemans P</AU>
<TI>Psychoeducation in bipolar disorder: Effect on expressed emotion</TI>
<SO>Psychiatry Research</SO>
<YR>1997</YR>
<VL>72</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kochman-2003" NAME="Kochman 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Kochman FJ, Hantouche EG, Meynard JA, Bayart D</AU>
<TI>A randomised trial of an interpersonal/cognitive behaviour intervention for preventing Bipolar disorder in depressed adolescents</TI>
<SO>Bipolar Disorder</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>1</NO>
<PG>113</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kornblith-1983" NAME="Kornblith 1983" YEAR="1983">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kornblith SJ, Rehm LP, O'Hara MW, Lamparski DM</AU>
<TI>The contribution of self reinforcement training and behavioural assignments to the efficacy of self control therapy for depression</TI>
<SO>Cognitive Therapy and Research</SO>
<YR>1983</YR>
<VL>7</VL>
<NO>6</NO>
<PG>499-528</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lapidus-2001" NAME="Lapidus 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lapidus LB, Shin SK, Hutton EM</AU>
<TI>An evaluation of six week intervention designed to facilitate coping with psychological stress</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>2001</YR>
<VL>57</VL>
<NO>12</NO>
<PG>1381-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-2004" NAME="Miller 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Miller IW, Solomon DA, Ryan CE, Keitner GI</AU>
<TI>Does adjunctive family therapy enhance recovery from Bipolar I mood episodes?</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2004</YR>
<VL>82</VL>
<NO>3</NO>
<PG>431-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monti-1980" NAME="Monti 1980" YEAR="1980">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Monti PM, Curran JP, Corriveau DP, Delancey AL, Hagerman SM</AU>
<TI>Effects of social skills training groups and sensitivity training groups with psychiatric patients</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1980</YR>
<VL>48</VL>
<NO>2</NO>
<PG>241-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Donnell-1999" NAME="O'Donnell 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>O'Donnell M, Parker G, Proberts M, Matthews R, Fisher D, Johnson B et al</AU>
<TI>A study of client focused case management and consumer advocacy: the community and consumer service project</TI>
<SO>Australian and New Zealand Journal of Psychiatry</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>5</NO>
<PG>684-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rea-2003" NAME="Rea 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rea MM, Tompson MC, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J</AU>
<TI>Family focused treatment versus individual treatment for Bipolar disorder : Results of a randomised clinical trial</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2003</YR>
<VL>71</VL>
<NO>3</NO>
<PG>482-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Souza-2003" NAME="Souza 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Souza RD, Keks N, Rich D, Diamond I, Godfrey K</AU>
<TI>An open randomised control study using a spiritually augmented cognitive behaviour therapy for demoralization and treatment adherence in patients with Bipolar 1 depression</TI>
<SO>Bipolar Disorder</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>1</NO>
<PG>51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tompson-2000" NAME="Tompson 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tompson MC, Rea MM, Goldstein MJ, Miklowitz DJ, Weisman AG</AU>
<TI>Difficulty in implementing a family intervention for bipolar disorder : the predictive role of patient and family attributes</TI>
<SO>Family Process</SO>
<YR>2000</YR>
<VL>39</VL>
<NO>1</NO>
<PG>105-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tyrer-1992" NAME="Tyrer 1992" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Merson S, Tyrer P, Onyett S, Lack S, Birkett P, Lynch S et al</AU>
<TI>Early intervention in psychiatric emergencies : a controlled clinical trial</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>339</VL>
<NO>8805</NO>
<PG>1311-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warning-1995" NAME="Warning 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Warning EM, Chamberlin CH, Carver CM, Stalker CA, Schaefer B</AU>
<TI>A pilot study of marital therapy as a treatment for depression</TI>
<SO>American Journal of Family Therapy</SO>
<YR>1995</YR>
<VL>23</VL>
<NO>1</NO>
<PG>3-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2000" NAME="Weiss 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA et al</AU>
<TI>Group therapy for patients with Bipolar disorder and substance dependence:results of a pilot study</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2000</YR>
<VL>61</VL>
<NO>5</NO>
<PG>361-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolk-1997" NAME="Wolk 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wolk R, Goldfarb AI</AU>
<TI>The response to group psychotherapy of aged recent admissions compared with long term mental hospital patients</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1967</YR>
<VL>123</VL>
<NO>10</NO>
<PG>1251-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Ball" NAME="Ball" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ball JR, Mitchell PB, Corry JC, Skilllecorn A, Smith M, Malhi GS</AU>
<TI>A randomised controlled trial of cognitive therapy for bipolar disorder : focus on long-term change</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2006</YR>
<VL>67</VL>
<NO>2</NO>
<PG>277-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Meyer-2003" NAME="Meyer 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;5th international conference on bipolar disorder&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Meyer TD, Hautzinger M</AU>
<TI>A randomised controlled trial of cognitive behaviour therapy and supportive therapy for bipolar disorders</TI>
<SO>Bipolar Disorders</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>1</NO>
<PG>135</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Altman-1992" NAME="Altman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Altman ES, Rea MM, Mintz J, Miklowitz DJ, Goldstein MJ, Hwang S</AU>
<TI>Prodromal symptoms and signs of bipolar relapse: a report based on prospectively collected data</TI>
<SO>Psychiatric Research</SO>
<YR>1992</YR>
<VL>27</VL>
<NO>1</NO>
<PG>245-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-1997" NAME="Altman 1997" TYPE="JOURNAL_ARTICLE">
<AU>Altman EG, Hedeker D, Peterson JL, Davis JM</AU>
<TI>The Altman Self-Rating Mania Scale</TI>
<SO>Biological Psychiatry</SO>
<YR>1997</YR>
<VL>42</VL>
<NO>10</NO>
<PG>948-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-1995" NAME="APA 1995" TYPE="BOOK">
<AU>American Psychiatric Association</AU>
<SO>Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV)</SO>
<YR>1995</YR>
<EN>4th</EN>
<PB>American Psychiatric Association</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ball-2003" NAME="Ball 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ball J, Mitchell P, Malhi G, Skillecorn A, Smith M</AU>
<TI>Schema - focused cognitive therapy for bipolar disorder : reducing vulnerability to relapse through attitudinal change.</TI>
<SO>Australian and New Zealand Journal of Psychiatry</SO>
<YR>2003</YR>
<VL>37</VL>
<NO>1</NO>
<PG>41-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bauer-1991" NAME="Bauer 1991" TYPE="JOURNAL_ARTICLE">
<AU>Bauer MS, Crits-Ctristoph P, Ball WA, Dewees , McAllister T, Alahi P et al</AU>
<TI>Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1991</YR>
<VL>48</VL>
<NO>9</NO>
<PG>807-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bech-1978" NAME="Bech 1978" TYPE="JOURNAL_ARTICLE">
<AU>Bech P, Rafaelsen OJ, Kramp P, Bolwig TG</AU>
<TI>Mania Rating Scale: Scale construction and interobserver agreement</TI>
<SO>Neuropharmacology</SO>
<YR>1978</YR>
<VL>17</VL>
<NO>6</NO>
<PG>430-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beck-1961" NAME="Beck 1961" TYPE="JOURNAL_ARTICLE">
<AU>Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J</AU>
<TI>An inventory for measuring depression</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1961</YR>
<VL>4</VL>
<PG>561-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birchwood-1989" NAME="Birchwood 1989" TYPE="JOURNAL_ARTICLE">
<AU>Birchwood M, Smith J, Macmillan F, Hogg B, Prasad R, Harvey C et al</AU>
<TI>Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation</TI>
<SO>Psychological Medicine</SO>
<YR>1989</YR>
<VL>19</VL>
<NO>3</NO>
<PG>649-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bowden-2000" NAME="Bowden 2000" TYPE="JOURNAL_ARTICLE">
<AU>Bowden C, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F et al</AU>
<TI>A randomized, placebo-controlled 12 month trial of divalproex and lithium in treatment of out-patients with bipolar 1 disorder. Divalproex Maintenance Study Group</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2000</YR>
<VL>57</VL>
<NO>5</NO>
<PG>481-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burgess-2003" NAME="Burgess 2003" TYPE="COCHRANE_REVIEW">
<AU>Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G</AU>
<TI>Lithium for maintenance treatment of mood disorders</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bustillo-1995" NAME="Bustillo 1995" TYPE="JOURNAL_ARTICLE">
<AU>Bustillo J, Buchanan RW, Carpenter T</AU>
<TI>Prodromal symptoms vs. early warning signs and clinical action in schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>4</NO>
<PG>553-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coryell-1989" NAME="Coryell 1989" TYPE="JOURNAL_ARTICLE">
<AU>Coryell W, Keller M, Endicott J, Andreasen N, Clayton P, Hirschfeld R</AU>
<TI>Bipolar ll illness: course and outcome over a five year period</TI>
<SO>Psychological Medicine</SO>
<YR>1989</YR>
<VL>19</VL>
<NO>1</NO>
<PG>129-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Denicoff-1999" NAME="Denicoff 1999" TYPE="JOURNAL_ARTICLE">
<AU>Denicoff KD, Alis SO, Mirsky AF, Smith-Jackson EE, Leverich GS, Duncan C et al</AU>
<TI>Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1999</YR>
<VL>56</VL>
<NO>1</NO>
<PG>67-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EuroQol-Group-1990" NAME="EuroQol Group 1990" TYPE="OTHER">
<AU>EuroQol Group</AU>
<TI>Euroqol EQ-5D - A new measurement of quality of life</TI>
<SO>Health Policy</SO>
<YR>1990</YR>
<VL>16</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gitlin-1995" NAME="Gitlin 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gitlin MJ, Swendsen J, Heller TL, Hammen C</AU>
<TI>Relapse and impairment in bipolar disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1995</YR>
<VL>152</VL>
<NO>11</NO>
<PG>1635-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goodwin-1990" NAME="Goodwin 1990" TYPE="BOOK">
<AU>Goodwin FK, Jamieson KR</AU>
<SO>Manic-depressive illness</SO>
<YR>1990</YR>
<PB>Oxford University Press</PB>
<CY>New York, NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hahn-2000" NAME="Hahn 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV</AU>
<TI>Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies</TI>
<SO>Statistics in Medicine</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>24</NO>
<PG>3325-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1960" NAME="Hamilton 1960" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton M</AU>
<TI>A rating scale for depression</TI>
<SO>Journal of Neurology, Neurosurgery and Psychiatry</SO>
<YR>1960</YR>
<VL>23</VL>
<PG>56-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hammen-1997" NAME="Hammen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hammen C, Gitlin M</AU>
<TI>Stress reactivity in bipolar patients and its relation to prior history of disorder</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<PG>856-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harrow-1990" NAME="Harrow 1990" TYPE="JOURNAL_ARTICLE">
<AU>Harrow M, Goldberg JF, Grossman LS, Meltzer HY</AU>
<TI>Outcome in manic disorders. A naturalistic follow-up study</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>7</NO>
<PG>665-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hill-1996" NAME="Hill 1996" TYPE="BOOK">
<AU>Hill RG, Shepherd G, Hardy P</AU>
<SO>A survey of the Manic Depression Fellowship</SO>
<YR>1996</YR>
<PB>Sainsbury Centre for Mental Health</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hurry-1983" NAME="Hurry 1983" TYPE="JOURNAL_ARTICLE">
<AU>Hurry J, Sturt E, Bebbington P, Tennant C.</AU>
<TI>Socio-demographic associations with social disablement in a community sample</TI>
<SO>Social Psychiatry</SO>
<YR>1983</YR>
<VL>18</VL>
<NO>3</NO>
<PG>113-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hutton-2000" NAME="Hutton 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hutton JL, Williamson PR</AU>
<TI>Bias in meta-analysis due to outcome variable selection within studies</TI>
<SO>Applied Statistics</SO>
<YR>2000</YR>
<VL>49</VL>
<PG>359-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jacobson-1965" NAME="Jacobson 1965" TYPE="JOURNAL_ARTICLE">
<AU>Jacobson JE</AU>
<TI>The hypomanic alert: a program designed for greater therapeutic control</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1965</YR>
<VL>122</VL>
<PG>295-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2005" NAME="Jones 2005" TYPE="CONFERENCE_PROC">
<AU>Jones AP, Williamson PR, Whitehead A, Riley R</AU>
<TI>Meta-analysis of Longitudinal Data</TI>
<SO>Royal Statistical Society Annual Conference 2005</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Joyce-1985" NAME="Joyce 1985" TYPE="JOURNAL_ARTICLE">
<AU>Joyce PR</AU>
<TI>Illness behaviour and rehospitalisation in bipolar affective disorder</TI>
<SO>Psychological Medicine</SO>
<YR>1985</YR>
<VL>15</VL>
<NO>3</NO>
<PG>521-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Judd-2002" NAME="Judd 2002" TYPE="JOURNAL_ARTICLE">
<AU>Judd LL, Akiskal HS, Schlettler PJ, Endicott J, Maser J, Solomon DA et al</AU>
<TI>The long-term natural history of the weekly symptomatic status of bipolar 1 disorder</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2002</YR>
<VL>59</VL>
<NO>6</NO>
<PG>530-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keller-1987" NAME="Keller 1987" TYPE="JOURNAL_ARTICLE">
<AU>Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P et al</AU>
<TI>The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1987</YR>
<VL>44</VL>
<NO>6</NO>
<PG>540-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keller-1992" NAME="Keller 1992" TYPE="JOURNAL_ARTICLE">
<AU>Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA et al</AU>
<TI>Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1992</YR>
<VL>49</VL>
<NO>5</NO>
<PG>371-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lam-1997" NAME="Lam 1997" TYPE="JOURNAL_ARTICLE">
<AU>Lam D, Wong G</AU>
<TI>Prodromes, coping strategies, insight and social functioning in bipolar affective disorders</TI>
<SO>Psychological Medicine</SO>
<YR>1997</YR>
<VL>27</VL>
<NO>5</NO>
<PG>1091-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lam-2003" NAME="Lam 2003" TYPE="JOURNAL_ARTICLE">
<AU>Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N et al</AU>
<TI>A randomised controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2003</YR>
<VL>60</VL>
<NO>2</NO>
<PG>145-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lish-1994" NAME="Lish 1994" TYPE="JOURNAL_ARTICLE">
<AU>Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM</AU>
<TI>The National MDA Survey of bipolar members</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1994</YR>
<VL>31</VL>
<NO>4</NO>
<PG>281-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miklowitz-2000" NAME="Miklowitz 2000" TYPE="JOURNAL_ARTICLE">
<AU>Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N et al</AU>
<TI>Family-focused treatment of Bipolar disorder: 1 year effects of a psychoeducational program in conjunction with pharmacotherapy</TI>
<SO>Biological psychiatry</SO>
<YR>2000</YR>
<VL>48</VL>
<PG>582-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Molnar-1988" NAME="Molnar 1988" TYPE="JOURNAL_ARTICLE">
<AU>Molnar G, Feeny M, Fava G</AU>
<TI>The duration and symptoms of bipolar prodromes</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1988</YR>
<VL>145</VL>
<NO>12</NO>
<PG>1575-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Montgomery-1979" NAME="Montgomery 1979" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery SA, Asberg M</AU>
<TI>A new depression rating scale designed to be sensitive to change</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1979</YR>
<VL>134</VL>
<PG>382-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morriss-2002" NAME="Morriss 2002" TYPE="JOURNAL_ARTICLE">
<AU>Morriss R, Marshall M, Harris A</AU>
<TI>Bipolar affective disorder - left out in the cold</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>324</VL>
<NO>7329</NO>
<PG>61-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morriss-2004" NAME="Morriss 2004" TYPE="JOURNAL_ARTICLE">
<AU>Morriss R</AU>
<TI>Teaching bipolar affective disorder patients how to recognize and manage early signs of relapse</TI>
<SO>Advances in Psychiatric Treatment</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>1</NO>
<PG>18-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mueser-2002" NAME="Mueser 2002" TYPE="JOURNAL_ARTICLE">
<AU>Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S et al</AU>
<TI>Illness management and recovery: A review of the research</TI>
<SO>Psychiatric Services</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>10</NO>
<PG>1272-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Connell-1991" NAME="O'Connell 1991" TYPE="JOURNAL_ARTICLE">
<AU>O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien BE</AU>
<TI>Outcome of bipolar disorder on long-term treatment with lithium</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1991</YR>
<VL>159</VL>
<PG>123-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ozer-2002" NAME="Ozer 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ozer S, Ulusahin A, Batur S, Kabakci E, Saka MC</AU>
<TI>Outcome measures of interepisode bipolar patients in a Turkish sample</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>2002</YR>
<VL>37</VL>
<NO>1</NO>
<PG>31-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parmar-1998" NAME="Parmar 1998" TYPE="JOURNAL_ARTICLE">
<AU>Parmar MK, Torri V, Stewart L</AU>
<TI>Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</TI>
<SO>Statistics in Medicine</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>24</NO>
<PG>2815-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perry-1995" NAME="Perry 1995" TYPE="JOURNAL_ARTICLE">
<AU>Perry A, Tarrier N, Morriss R</AU>
<TI>Identification of prodromal signs and symptoms and early intervention in manic depressive psychosis patients: a case example</TI>
<SO>Behavioural and Cognitive Psychotherapy</SO>
<YR>1995</YR>
<VL>23</VL>
<NO>4</NO>
<PG>399-409</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Robins-1984" NAME="Robins 1984" TYPE="JOURNAL_ARTICLE">
<AU>Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr et al</AU>
<TI>Lifetime prevalence of specific psychiatric disorders in three sites</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1984</YR>
<VL>41</VL>
<NO>10</NO>
<PG>949-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scott-2006a" NAME="Scott 2006a" NOTES="&lt;p&gt;In press&lt;/p&gt;" TYPE="UNPUBLISHED">
<AU>Scott J, Colom F, Vieta E</AU>
<TI>Psychological therapies in bipolar disorders: a meta-analysis</TI>
<SO>International Journal of Neuropsychopharmacology</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simoneau-1999" NAME="Simoneau 1999" TYPE="JOURNAL_ARTICLE">
<AU>Simoneau TL, Miklowitz DJ, Richards JA, Saleem R, George EL</AU>
<TI>Bipolar Disorder and family communication: Effects of a psychoeducational treatment program</TI>
<SO>Journal of Abnormal Psychology</SO>
<YR>1999</YR>
<VL>108</VL>
<NO>4</NO>
<PG>588-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1992" NAME="Smith 1992" TYPE="JOURNAL_ARTICLE">
<AU>Smith J, Tarrier N</AU>
<TI>Prodromal symptoms in manic depressive psychosis</TI>
<SO>Social Psychiatry and Psychiatric Epidemiology</SO>
<YR>1992</YR>
<VL>27</VL>
<NO>5</NO>
<PG>245-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ten-Have-2002" NAME="ten Have 2002" TYPE="JOURNAL_ARTICLE">
<AU>ten Have M , Vollebergh W , Bijl R , Nolen WA</AU>
<TI>Bipolar disorder in the general population in the Netherlands ( prevalance , consequences and care utilisation ) : results from The Netherlands Mental health survey and incidence study (NEMESIS)</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2002</YR>
<VL>68</VL>
<NO>2-3</NO>
<PG>203-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tohen-1990" NAME="Tohen 1990" TYPE="JOURNAL_ARTICLE">
<AU>Tohen M, Waternaux GM, Tsuang MT</AU>
<TI>Outcome in mania: a 4-year prospective follow-up of 75 patients utilising survival analysis</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>12</NO>
<PG>1106-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williamson-2005" NAME="Williamson 2005" TYPE="JOURNAL_ARTICLE">
<AU>Wiiliamson PR, Gamble C, Altman DG, Hutton JL</AU>
<TI>Outcome selection bias in meta-analysis</TI>
<SO>Statistical Methods in Medical Research</SO>
<YR>2005</YR>
<VL>14</VL>
<PG>515-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williamson-2005-a" NAME="Williamson 2005 a" TYPE="JOURNAL_ARTICLE">
<AU>Williamson PR, Gamble C</AU>
<TI>Identification and impact of outcome selection bias in meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2005</YR>
<VL>24</VL>
<PG>1547-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Young-1978" NAME="Young 1978" TYPE="JOURNAL_ARTICLE">
<AU>Young RC, Biggs VT, Ziegler VE, Meyer DA</AU>
<TI>A rating scale for mania: reliability, validity and sensitivity</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1978</YR>
<VL>133</VL>
<PG>429-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zigmond-1983" NAME="Zigmond 1983" TYPE="JOURNAL_ARTICLE">
<AU>Zigmond AS, Snaith RP</AU>
<TI>The Hospital Anxiety and Depression Scale</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1983</YR>
<VL>67</VL>
<NO>6</NO>
<PG>361-70</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Colom-2003b">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : 20 weeks treatment phase, 24 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 (DSM1V) based on opinion of senior psychiatrist<BR/>Age - 18 to 65, mean(sd) 34.5(7.8) in treatment and 35.4(10.9) in control<BR/>Sex 64% females in control , 60% females in treatment group<BR/>History : Excludes axis 1 comorbidity. <BR/>Number of previous episodes (7-11)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 25. seen by their psychiatrist every four weeks. The group met every week in group of eight to twelve patients without any special instruction from same therapists.</P>
<P>TAU + Psychoeducation ( reports as 20 sessions of 90 minutes each. programme delivered by two experienced psychologists ) N = 25.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any reccurrence,manic reccurence, mixed recurence, depressive recurrence.<BR/>Percentage of people hospitalised.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Colom-2003c">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : 21 weeks treatment phase, 24 months follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 and 11 (DSM1V) based on opinion of senior psychiatrist<BR/>Age - 18 to 65<BR/>Sex - 63% females in control , 63% female in tretment group<BR/>History : Excludes axis 1 comorbidity.<BR/>Number of previous episodes (7-11)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 60. Patients seen by two psychiatrists every four weeks. Control group met every week in groups of eight to twelve without special instructions from the same therapist. <BR/>TAU + Psychoeducation ( 21 sessions of 90 minutes . conducted by two experienced psychologist ) N = 60</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any recurrence,manic recurence, mixed recurence, depressive recurrence.<BR/>Percentage of people hospitalised.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lam-2000">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : Therapy for six months and 12 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 (DSM1V) , no more details given .<BR/>Age - 18 to 65, mean(sd) 39.0(10.9)yrs<BR/>Sex ( F :M )12:13 <BR/>History : Excludes axis 1 comorbidity.<BR/>Number of previous episodes (7-11)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 12 delivered by multidisciplinary team .<BR/>TAU + Psychoeducation ( reports as 12 to 20 sessions within six months . Therapists were clinical psychologists with a minimum of six years postqualification experience ) N = 13</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>
<BR/>Mean number of bipolar episodes, depressed episode , hypomanic episode and total bipolar episodes (these couldnt be used )HDRS score at 12 months<BR/>BDI score at 12 months<BR/>Measure of functioning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lam-2005">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : 12 to 18 sessions in first six months and two booster sessions in second six months .<BR/> 24 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 (DSM1V) based on SCID by research assisstant<BR/>Age - 18 to 70, mean(sd) 46.4(12.1) in treatment and 41.5(10.8) in control<BR/>Sex ( F :M )28:51 in control , 30:52 in treatment group<BR/>History : Excludes axis 1 comorbidity.<BR/>Number of previous episodes (7-11)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 52<BR/>TAU + Psychoeducation ( 12 to 18 sessions. The therapists were clinical psychologists with a minimum five years post qualification experience. ) N = 51</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any reccurrence,manic reccurence depressive recurrence.<BR/>Measure of functioning</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Meyer-2003a">
<CHAR_METHODS>
<P>See table under ongoing studies</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>See table under ongoing studies</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>See table under ongoing studies</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>See table under ongoing studies</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Miklowitz-2003">
<CHAR_METHODS>
<P>Allocation : Randomised (2:1)<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : nine months treatment , 24 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 (DSM111-R) using structured psychiatric interview by research assisstant<BR/>Age - 18 to 60, mean(sd) 35.7(9.2)yrs in treatment group and 35.6(10.6) in control group.<BR/>Sex ( F :M )18:13 in treatment group and 46:24 in control group.<BR/>History : axis 1 comorbidity - not stated.</P>
<P>Number of previous episodes (1-6)</P>
<P>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 70 . This group received two sessions of family education in addition to clinical input / crisis management.<BR/>TAU + Psychoeducation N = 31<BR/>21 sessions of an hour each</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>
<BR/>Time to any reccurrence. Total number of hospitalization but data couldnt be used as there was no separate data on control and treatment.</P>
<P>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Perry-1999">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : 18 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 and Bipolar 11 (DSM111-R) based on SCID by a trained research asisstant.<BR/>Age - 18 to 75, mean(sd) 44(13) in treatment and 45(11) in control<BR/>Sex ( F :M )24:11 in control , 23:11 in treatment group<BR/>History : Includes axis 1 comorbidity.<BR/>Number of previous episodes (1-6)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 35<BR/>TAU + Psychoeducation ( reports as seven to 12 sessions of one hour each by research psychologist with little previous experience ) N = 34</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any reccurrence,manic reccurence depressive recurrence. HDRS, MRC social functioning scale.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Scott-2001">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blinding unclear<BR/>Duration : six months treatment . 18 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 or 11 based on SADS by independent research psychiatrist.<BR/>Age - &gt; 18 mean(sd) 37.8 (8.7)yrs in treatment group and 40.5 (6.7) in control group.<BR/>Sex ( F :M )14:7 in treatment group and 11:10 in control group. <BR/>History : includes axis 1 comorbidity.<BR/>Number of previous episodes (1-6)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 21<BR/>TAU + Psychoeducation ( 14 sessions of 45 minutes each by two experienced therapists. ) N = 21</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>GAF , ISS , WASA , BDI, Number of patients relapsed.<BR/>None used.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Scott-2006">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : held weekly for 15 weeks and then with gradually decreasing frequency until 26 weeks. <BR/> 18 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 and Bipolar 11 (DSM1V ) based on SCID <BR/>Age - &gt;18 mean(sd) 42.7(11.4) in control and 39.7(10.3) in treatment<BR/>Sex ( F :M )85:40 in treatment , 79:47 in control group<BR/>History : Includes axis 1 comorbidity.<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 126<BR/>TAU + Psychoeducation ( reports as 20 sessions. Delivered by accredited therapists. ) N = 127</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any reccurence, manic reccurence depressive recurrence.<BR/>Measure of functioning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Simon-2004">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None , Outcome assessor blind<BR/>Duration : 12 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 and 11 (DSM1V) using SCID and record review by senior psychiatrist.<BR/>Age - &gt; 18 mean(sd) 44.1(13.4)yrs in treatment group and 44.3(12.9) in control group.<BR/>Sex ( F :M )144:212 in treatment group and 157:229 in control group. <BR/>History : includes axis 1 comorbidity.<BR/>Number of previous episodes (not stated)<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 229<BR/>TAU + Psychoeducation ( Five weekly group sessions followed by twice monthly sessions for 12 months ) N = 212</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>
<BR/>Percentage of people hospitalised.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Van-Gent-1991">
<CHAR_METHODS>
<P>Allocation : Randomised<BR/>Blinding : None<BR/>Duration : 6 months follow up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar patients (DSM 111 R ) based on opinion of two independent psychiatrist.<BR/>Age - mean(sd) 44(11)yrs in treatment group and 55 (10) in control group.<BR/>Sex ( F :M ) - not stated.<BR/>History : axis 1 comorbidity -not stated.<BR/>Number of previous episodes - not stated<BR/>Setting : Secondary care</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TAU N = 12<BR/>TAU + Psychoeducation ( reports as five sessions ) N = 14</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>None used</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Beardslee-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Beardslee-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate study (same as Beardslee 1992)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Becker-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Burns-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with bipolar disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Clarkin-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate study (same as Glick 1993)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cochran-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Draine-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with bipolar disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Drake-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Elixhauser-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with bipolar disorder and intervention did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Frank-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Both treatment groups received early warning sign intervention, which is an exclusion criterion in this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Glick-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Honig-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kochman-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with diagnosis of bipolar disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kornblith-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with diagnosis of bipolar disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lapidus-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Miller-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Monti-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with diagnosis of bipolar disorder and interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-O_x0027_Donnell-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Interventions did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rea-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Both control group and treatment group included early signs of recurrence as part of their intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Souza-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention did not include early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tompson-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tyrer-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include people with early signs of recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Warning-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Population did not include adults with diagnosis of bipolar disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weiss-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wolk-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Ball">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR STUDY_ID="STD-Meyer-2003">
<CHAR_STUDY_NAME>
<P>Cognitive Behaviour Therapy and Supportive Therapy</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>Diagnosis : Bipolar 1 or 11 (DSM 1V , SCID) does not say who made the diagnosis.<BR/>Age : 44.4 (SD==11) in TAU + CBT and 43.5 ( (SD=12.7) in TAU.<BR/>Sex : 47% female in Treatment group and 53% in control<BR/>Unclear if axis 1 comorbidity was included or excluded.</P>
<P>Age :18 - 65 , Mean(sd) 44.4(11) in treatment group and 43.5(12.7) in control group</P>
<P>Sex : 47.4% in treatment group and 52.6% in control group.</P>
<P>Setting : Secondary care</P>
<P/>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Interventions : <BR/>TAU N=38. <BR/>TAU + Psychoeducation N = 38. Both the groups received psychoeducation plus TAU for 20 sessions of 50 minute each for a period of 9 months. The psychoeducation in control group did not include EWS.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Time to any recurrence -not reported.<BR/>Time to manic episode - not reported<BR/>Time to depressive episode - not reported<BR/>HAMD,YMRS, GAS scores at 3 months given . Reported number of days in hospital.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>Poster published in Bipolar Disorders journal and 3 month data was supplied by the Author</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Colom-2003b">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Colom-2003c">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Meyer-2003a">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Miklowitz-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Perry-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Scott-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Scott-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Simon-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Gent-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES>
<ADDITIONAL_TABLE ID="TBL-01" NO="1">
<TITLE>Methodological quality of included studies</TITLE>
<TABLE COLS="5" ROWS="12">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Allocation</P>
</TH>
<TH>
<P>Randomisation</P>
</TH>
<TH>
<P>Blinding</P>
</TH>
<TH>
<P>ITT</P>
</TH>
</TR>
<TR>
<TD>
<P>Colom 2003</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>by computerised number generator</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>ITT principle used</P>
</TD>
</TR>
<TR>
<TD>
<P>Colom 2003 (a)</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>by computerised number generator</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>ITT principle used</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2005</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>computer generated allocation sequence</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>reports ITT principle used, but data missing for primary outcome and not reported reasons for it.</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>randomisation procedure not described</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>Reports ITT principle used. Data on two patients who dropped out not reported.</P>
</TD>
</TR>
<TR>
<TD>
<P>Meyer 2003</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>randomisation not described.</P>
</TD>
<TD>
<P>not described</P>
</TD>
<TD>
<P>ongoing study</P>
</TD>
</TR>
<TR>
<TD>
<P>Miklowitz 2003</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>randomisation by random number table. 2:1 randomisation used.</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>accounted for all patients but does not state whether ITT principle was used.</P>
</TD>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>randomly allocated using principles of minimisation</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>ITT principle used. Data on one patient missing as patient died due to physical cause</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2005</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>independent trialists and biostatistics office allocated patients to two treatment groups using minimisation algorithm</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>ITT principle used. Results on four people missing and these were included in final analysis.</P>
</TD>
</TR>
<TR>
<TD>
<P>Simon 2004</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>using a concealed table of computer generated random numberswith no blocking or staratification</P>
</TD>
<TD>
<P>Only outcome asessor blinded</P>
</TD>
<TD>
<P>ITT principle used. In treatment group 199/212 were included for symptom analysis and all included for utilisation analysis. in control group 215/229 were included in symptom analysis and all were included in utilization analysis.</P>
</TD>
</TR>
<TR>
<TD>
<P>Vangent 1991</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>not described</P>
</TD>
<TD>
<P>no blinding , unclear if outcome asessor was blinded</P>
</TD>
<TD>
<P>All participants accounted for but does not state whether ITT principle was used.</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" NO="2">
<TITLE>Comparison of baseline demographics of studies that reported primary outcomes</TITLE>
<TABLE COLS="7" ROWS="16">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Colom 2003</P>
</TH>
<TH>
<P>Colom 2003 (a)</P>
</TH>
<TH>
<P>Lam 2005</P>
</TH>
<TH>
<P>Perry 1999</P>
</TH>
<TH>
<P>Scott 2005</P>
</TH>
<TH>
<P>Miklowitz 2003</P>
</TH>
</TR>
<TR>
<TD>
<P>AGE<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
</P>
</TD>
<TD>
<P>
<BR/>18 -65<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
<BR/>
</P>
</TD>
<TD>
<P>18-65 , mean (sd) 34.5 (7.8) in T and 35.4 (10.9) in C</P>
</TD>
<TD>
<P>18-70 , mean (sd) 46.4(12.1) in Treatment and 41.5 (10.8) in Control</P>
</TD>
<TD>
<P>18-75 , mean (sd) 44(13) in Treatment and 45 (11) in Control</P>
</TD>
<TD>
<P>&gt;18 mean(sd) 42.7(11.4) in C and 39.7(10.3) in T</P>
</TD>
<TD>
<P>18-60,mean(sd) 35.7(9.2) in T and35.6(10.6) in C</P>
</TD>
</TR>
<TR>
<TD>
<P>GENDER</P>
</TD>
<TD>
<P>63.3%femalesin control, 63.3%females in treatment</P>
</TD>
<TD>
<P>F:M (15:10) in control , (16:9) in treatment</P>
</TD>
<TD>
<P>F:M (28:51) in control , (30:52) in treatment</P>
</TD>
<TD>
<P>F:M (24:35) in control , (23:34) in treatment</P>
</TD>
<TD>
<P>F:M(85:127) in T And 79:126 in C</P>
</TD>
<TD>
<P>F:M(18:31) in TAnd (46:72) in C</P>
</TD>
</TR>
<TR>
<TD>
<P>REFERRAL SOURCE</P>
</TD>
<TD>
<P>Secondarycare</P>
</TD>
<TD>
<P>secondary care</P>
</TD>
<TD>
<P>secondary care</P>
</TD>
<TD>
<P>secondary care</P>
</TD>
<TD>
<P>Secondary care</P>
</TD>
<TD>
<P>Secondary care</P>
</TD>
</TR>
<TR>
<TD>
<P>MARITALSTATUS</P>
</TD>
<TD>
<P>Not stated<BR/>
<BR/>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>22/34 in treatment and 21/35 in control were married or cohabiting</P>
</TD>
<TD>
<P>Cohabiting56/126 in C and46/127 in T</P>
</TD>
<TD>
<P>Not clear but requiredContact with carer<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>IN EPISODEOR NOT</P>
</TD>
<TD>
<P>Euthymic only</P>
</TD>
<TD>
<P>Euthymic only</P>
</TD>
<TD>
<P>currently not fulfilling bipolar disorder criteria</P>
</TD>
<TD>
<P>Euthymic</P>
</TD>
<TD>
<P>Yes , except mania</P>
</TD>
<TD>
<P>Recruited shortly after Onset of acute episode but <BR/>proportion unclear</P>
</TD>
</TR>
<TR>
<TD>
<P>HOW LONG FROM PREVIOUS EPISODE</P>
</TD>
<TD>
<P>In remission For atleast6 months</P>
</TD>
<TD>
<P>At least six months</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>mean (sd) in weeks 25(16) in treatment and 25(18) in control</P>
</TD>
<TD>
<P>Included those inEpisode exceptMania.</P>
</TD>
<TD>
<P>Most in episode</P>
</TD>
</TR>
<TR>
<TD>
<P>NUMBER OF PAST EPISODE</P>
</TD>
<TD>
<P>7-11<BR/>
</P>
</TD>
<TD>
<P>7-11</P>
</TD>
<TD>
<P>7-11</P>
</TD>
<TD>
<P>1-6</P>
</TD>
<TD>
<P>2-6 episodes ( 39 in C and 35 in T )<BR/>7-11 episodes ( 29 in C and 25 in T )<BR/>12-29 episode ( 27 in C and 32 in T )<BR/>30 + episode ( 31 in C and 35 in T )<BR/>
</P>
</TD>
<TD>
<P>1-6</P>
</TD>
</TR>
<TR>
<TD>
<P>SUBSTANCE MISUSE</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>Excluded substanceAbuse and dependenceIn last 6 months</P>
</TD>
</TR>
<TR>
<TD>
<P>RAPID CYCLING</P>
</TD>
<TD>
<P>Included, Unclear what proportion<BR/>
<BR/>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>not stated</P>
</TD>
</TR>
<TR>
<TD>
<P>PERSONALITY DISORDER</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>not clear</P>
</TD>
</TR>
<TR>
<TD>
<P>PHYSICAL ILLNESS</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>excluded neurological problems , others not clear<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>PSYCHOTIC SYMPTOMS</P>
</TD>
<TD>
<P>Present, 42/60In C and 47/60 In T , P=NS<BR/>
</P>
</TD>
<TD>
<P>Present, 19/25 In Control and 23/25 In Treatment , P=NS</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>not clear</P>
</TD>
</TR>
<TR>
<TD>
<P>SUICIDE ATTEMPTS<BR/>
</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>not clear</P>
</TD>
</TR>
<TR>
<TD>
<P>AXIS 1 CO-MORBIDITY</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>excluded</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>included</P>
</TD>
<TD>
<P>not clear<BR/>
<BR/>
<BR/>
<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" NO="3">
<TITLE>Comparison of focus of intervention of studies that reported primary outcome</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Colom 2003</P>
</TH>
<TH>
<P>Colom 2003(a)</P>
</TH>
<TH>
<P>Lam 2005</P>
</TH>
<TH>
<P>Perry 1999</P>
</TH>
<TH>
<P>Scott 2005</P>
</TH>
<TH>
<P>Miklowitz 2003</P>
</TH>
</TR>
<TR>
<TD>
<P>EWS as primary Focus</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS to patient Only</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS to patient And Carer or Health worker</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS delivered Individually</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS delivered In groups</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS promoting Only help seekingFrom others</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>EWS promoting Additional self-Directed coping</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>no</P>
</TD>
<TD>
<P>yes</P>
</TD>
<TD>
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" NO="4">
<TITLE>Comparison of intervention of studies that reported primary outcome</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TH>
<P>Study Id</P>
</TH>
<TH>
<P>Colom 2003</P>
</TH>
<TH>
<P>Colom 2003 (a)</P>
</TH>
<TH>
<P>Lam 2005</P>
</TH>
<TH>
<P>Perry 1999</P>
</TH>
<TH>
<P>Scott 2005</P>
</TH>
<TH>
<P>Miklowitz 2003</P>
</TH>
</TR>
<TR>
<TD>
<P>Duration</P>
</TD>
<TD>
<P>21 weeks , weekly sessions</P>
</TD>
<TD>
<P>20 weeks , weekly sessions</P>
</TD>
<TD>
<P>12 - 18 individual sessions in first six months and 2 booster in second 6 months</P>
</TD>
<TD>
<P>7-12 sessions of one hour each. 18 mths followup.</P>
</TD>
<TD>
<P>Weekly sessionsFor 15 weeks and Then reducing Frequency tillWeek 26</P>
</TD>
<TD>
<P>9 months ( 12 weekly then 6 biweekly then 3 monthly)</P>
</TD>
</TR>
<TR>
<TD>
<P>Who did it</P>
</TD>
<TD>
<P>Two experienced psychologist</P>
</TD>
<TD>
<P>Two experienced psychologist</P>
</TD>
<TD>
<P>Clinical Psychologists With a minimum Of 5 yrs post Qualification Experience</P>
</TD>
<TD>
<P>Research Psychologist withLittle previous experience</P>
</TD>
<TD>
<P>Therapist with Minimum criteria to Be accredited as CBT therapist in Europe with regular Supervision.</P>
</TD>
<TD>
<P>Therapist with regular Supervision.</P>
</TD>
</TR>
<TR>
<TD>
<P>No. of sessionAttended</P>
</TD>
<TD>
<P>21 sessions of 90 minutes each =1890 minut</P>
</TD>
<TD>
<P>1800 minutes</P>
</TD>
<TD>
<P>13.9 + 5.5 sessions</P>
</TD>
<TD>
<P>7 to 12 sessions ofOne hour each ,Median nine =540 minutesrange 0-12</P>
</TD>
<TD>
<P>20 sessionsplus two booster session offered at weeks 32 and 38.</P>
</TD>
<TD>
<P>21 sessions of one hour each</P>
</TD>
</TR>
<TR>
<TD>
<P>Control group</P>
</TD>
<TD>
<P>Standard pharmacologic treatment and an intervention consisting of 20 weekly group meetings of 8-12 patients with the same psychologists who were involved with treatment group. The psychologists tried not to give any psychoeducational feedback except for that necessary for patient interaction. They were reviewed by their psychiatrist at four weekly intervals.</P>
</TD>
<TD>
<P>Seen by psychiatrist every four weeks and standard pharmacological treatment. Patients met every week in groups of 8 to 12 patients without special instructions from therapist.</P>
</TD>
<TD>
<P>- Control group received mood stabilisers at a recommended level according to BNF with regular psychiatric follow up as outpatients.<BR/>
<BR/>
</P>
</TD>
<TD>
<P>delivered by psychiatrists and key workers consisted of drug treatment , monitoring of mood and adherence to treatment , support , education about bipolar disorder and if necessary inpatient care.</P>
</TD>
<TD>
<P>- by usual psychiatric team. This included prescription of medication and contact with key mental health professionals with whatever frequency considered appropriate.</P>
</TD>
<TD>
<P>- two sessions ( ONE HOUR EACH ) of family education plus crisis intervention sessions as needed.<BR/>Study physicians were allowed to adjust the frequency of clinic visits and drug and dosage choices to the needs of the <BR/>individual patients.<BR/>
<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" NO="5">
<TITLE>Comparison 01: TAU vs TAU+EWS</TITLE>
<TABLE COLS="5" ROWS="5">
<TR>
<TH>
<P>Outcome Title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to any relapse</P>
</TD>
<TD>
<P>six</P>
</TD>
<TD>
<P>690</P>
</TD>
<TD>
<P>Hazards ratio random effect 95% CI</P>
</TD>
<TD>
<P>0.57 ( 0.39 , 0.82 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to hypomanic /manic relapse</P>
</TD>
<TD>
<P>four</P>
</TD>
<TD>
<P>533</P>
</TD>
<TD>
<P>Hazards ratio random effect 95% CI</P>
</TD>
<TD>
<P>0.66 ( 0.40 , 1.06 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to depressive relapse</P>
</TD>
<TD>
<P>four</P>
</TD>
<TD>
<P>533</P>
</TD>
<TD>
<P>Hazards ratio random effect 95% CI</P>
</TD>
<TD>
<P>0.57 ( 0.33 , 0.99 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Percentage of people hospitalised</P>
</TD>
<TD>
<P>four</P>
</TD>
<TD>
<P>679</P>
</TD>
<TD>
<P>Hazards ratio fixed effect 95% CI</P>
</TD>
<TD>
<P>1.49 ( 1.05 , 2.11 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" NO="6">
<TITLE>Comparison 02 01</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>time to recurrence of any type for TAU + EWS intervention in control group</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>520</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.65 ( 0.41 , 1.03 )</P>
</TD>
</TR>
<TR>
<TD>
<P>time to recurrence of any type for TAU + psychological intervention in <BR/>control group</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>170</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.65 ( 0.39 , 1.09 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" NO="7">
<TITLE>Comparison 02 02</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>time to manic / hypomanic relapse for TAU + EWS intervention</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>413</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.70 ( 0.39 , 1.25 )</P>
</TD>
</TR>
<TR>
<TD>
<P>time to manic / hypomanic relapse for TAU + psychological intervention</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>120</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.52 ( 0.33 , 0.82 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" NO="8">
<TITLE>Comparison 02 03</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>time to depressive episode for TAU + EWS intervention</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>413</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.66 ( 0.36 , 1.22 )</P>
</TD>
</TR>
<TR>
<TD>
<P>time to depressive episode for TAU + psychological intervention</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>120</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.38 ( 0.24 , 0.62 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" NO="9">
<TITLE>Comparison 02 04</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type for studies using only TAU for control group</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>419</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.76 ( 0.49 , 1.18 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type for studies using enhanced TAU for control group</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>101</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.38 ( 0.20 , 0.72 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-10" NO="10">
<TITLE>Comparison 02 05</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type for intervention delivered individually</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>419</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.76 ( 0.49 , 1.18 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type for intervention delivered in groups</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>271</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.56 ( 0.37 , 0.87 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-11" NO="11">
<TITLE>Comparison 02 06</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to first recurrence for any type in those studies which recruit patients one month after episode</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>336</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.62 ( 0.48 , 0.80 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to first recurrence for any type in those studies which recruit patients during episode</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>354</P>
</TD>
<TD>
<P>hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.66 ( 0.24 , 1.77 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-12" NO="12">
<TITLE>Comparison 02 07</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No. of studies</P>
</TH>
<TH>
<P>No. of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type in those studies with simple intervention for EWS</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>Hazards ratio , Random effect <BR/> 95% CI</P>
</TD>
<TD>
<P>0.74 ( 0.43 , 1.28 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type in those studies with complex intervention for EWS<BR/>
</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>622</P>
</TD>
<TD>
<P>Hazards ratio , Random effect<BR/> 95% CI</P>
</TD>
<TD>
<P>0.54 ( 0.35 , 0.83 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-13" NO="13">
<TITLE>Comparison 02 08</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Otcome title</P>
</TH>
<TH>
<P>No. of studies</P>
</TH>
<TH>
<P>No. of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to manic / hypomanic episode for studies with simple intervention for EWS</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>Hazards ratio , random effect 95% CI</P>
</TD>
<TD>
<P>0.37 ( 0.18 - 0.77 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to manic / hypomanic episode for studies with complex intervention for EWS</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>465</P>
</TD>
<TD>
<P>Hazards ratio , random effect 95% CI</P>
</TD>
<TD>
<P>0.76 ( 0.46 - 1.26 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-14" NO="14">
<TITLE>Comparison 02 09</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to depressive episode in those studies with simple intervention for EWS</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>Hazards ratio , random effect <BR/>95% CI</P>
</TD>
<TD>
<P>0.63 ( 0.31 - 1.27 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to depressive episode in those studies with complex intervention for EWS</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>465</P>
</TD>
<TD>
<P>Hazards ratio , random effect <BR/>95% CI</P>
</TD>
<TD>
<P>0.55 ( 0.26 - 1.13 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-15" NO="15">
<TITLE>Comparison 02 10</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Otcome title</P>
</TH>
<TH>
<P>No. of studies</P>
</TH>
<TH>
<P>No. of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type where Ews was the primary focus of intervention</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>437</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95%CI</P>
</TD>
<TD>
<P>0.58 ( 0.45 - 0.73 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to first recurrence of any type where EWS was secondary focus of intervention</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>253</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95%CI</P>
</TD>
<TD>
<P>1.05 ( 0.74 - 1.49 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-16" NO="16">
<TITLE>Comparison 02 11</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to manic / hypomanic episode for studies where EWS was used as primary focus of the intervention</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>280</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.53 ( 0.38 - 0.74 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to manic / hypomanic episode for studies where EWS was used as secondary focus of the intervention</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>253</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>1.05 ( 0.74 - 1.49 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-17" NO="17">
<TITLE>Comparison 02 12</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Outcome title</P>
</TH>
<TH>
<P>No of studies</P>
</TH>
<TH>
<P>No of participants</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Time to depressive episode in studies which used EWS as primary focus of intervention</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>280</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>0.43 (0.31 - 0.61 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Time to depressive episode in studies which used EWS as primary focus of intervention</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>253</P>
</TD>
<TD>
<P>Hazards ratio , random effect , 95% CI</P>
</TD>
<TD>
<P>1.04 ( 0.69 - 1.57 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-18" NO="18">
<TITLE>Meta-regression analyses</TITLE>
<TABLE COLS="5" ROWS="3">
<TR>
<TH>
<P>Factor</P>
</TH>
<TH>
<P>Number of Studies</P>
</TH>
<TH>
<P>Slope Estimate</P>
</TH>
<TH>
<P>95% CI</P>
</TH>
<TH>
<P>p-value</P>
</TH>
</TR>
<TR>
<TD>
<P>Non-psychological / psychological intervention</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>0.018</P>
</TD>
<TD>
<P>(-0.727 to 0.762)</P>
</TD>
<TD>
<P>0.963</P>
</TD>
</TR>
<TR>
<TD>
<P>Inclusion six month after episode / during and immediately after episode</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>0.979</P>
</TD>
<TD>
<P>(0.615 to 0.81)</P>
</TD>
<TD>
<P>0.788</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-19" NO="19">
<TITLE>BDI score (Mean, SD)</TITLE>
<TABLE COLS="8" ROWS="5">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>score at ( months )</P>
</TH>
<TH>
<P>No in C group</P>
</TH>
<TH>
<P>No in T group</P>
</TH>
<TH>
<P>Control group score</P>
</TH>
<TH>
<P>Treatment group scor</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>six</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>7.60 ( 8.92)</P>
</TD>
<TD>
<P>4.83 ( 6.10 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>2.77 ( -3.53 , 9.07 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>11.56 ( 13.88 )</P>
</TD>
<TD>
<P>6.18 ( 8.44 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>5.38 ( -4.11 , 14.87 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>85</P>
</TD>
<TD>
<P>81</P>
</TD>
<TD>
<P>9.30 ( 10.90 )</P>
</TD>
<TD>
<P>9.40 ( 11.00 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.10 ( -3.43 , 3.23 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>85</P>
</TD>
<TD>
<P>81</P>
</TD>
<TD>
<P>8.30 ( 10.50 )</P>
</TD>
<TD>
<P>8.00 ( 8.10 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>0.30 ( -2.55 , 3.15 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-20" NO="20">
<TITLE>HDRS Score (Mean, SD)</TITLE>
<TABLE COLS="8" ROWS="9">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Score at ( months )</P>
</TH>
<TH>
<P>No in C group</P>
</TH>
<TH>
<P>No in T group</P>
</TH>
<TH>
<P>Control group score</P>
</TH>
<TH>
<P>Treatment group scor</P>
</TH>
<TH>
<P>Satistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>3.40 ( 4.00 )</P>
</TD>
<TD>
<P>4.00 ( 3.90 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.60 ( -2.66 , 1.46 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>4.10 (5.30 )</P>
</TD>
<TD>
<P>3.30 ( 3.50 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>0.80 ( -1.49 , 3.09 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Eighteen</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>3.90 ( 4.40 )</P>
</TD>
<TD>
<P>5.00 ( 6.00 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-1.10 ( -3.90 , 1.70 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>5.30 ( 6.96 )</P>
</TD>
<TD>
<P>4.17 ( 5.39 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>1.13 ( -3.99 , 6.25 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>9.40 ( 9.47 )</P>
</TD>
<TD>
<P>4.00 ( 5.66 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>5.40 ( -1.05 , 11.85 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>6.20 ( 6.20 )</P>
</TD>
<TD>
<P>5.40 ( 5.60 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>0.80 ( -0.92 , 2.52 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>6.10 ( 6.90 )</P>
</TD>
<TD>
<P>6.30 ( 5.70 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.20 ( -2.04 , 1.64 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Eighteen</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>6.00 ( 6.30 )</P>
</TD>
<TD>
<P>7.10 ( 6.70 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-1.10 ( -3.00 , 0.80 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-21" NO="21">
<TITLE>BRMS Score (Mean, SD)</TITLE>
<TABLE COLS="8" ROWS="7">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Score at ( months )</P>
</TH>
<TH>
<P>No in C group</P>
</TH>
<TH>
<P>No in T group</P>
</TH>
<TH>
<P>Control group scores</P>
</TH>
<TH>
<P>Treatment group scor</P>
</TH>
<TH>
<P>Satistical method</P>
</TH>
<TH>
<P>Effect size</P>
</TH>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>0.30 ( 0.70 )</P>
</TD>
<TD>
<P>0.40 ( 1.10 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.10 ( -0.57 , 0.37 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>0.04 ( 0.20 )</P>
</TD>
<TD>
<P>0.50 ( 1.30 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.46 ( -0.92 , 0.00 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Perry 1999</P>
</TD>
<TD>
<P>Eighteen</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>0.20 ( 0.70 )</P>
</TD>
<TD>
<P>0.40 ( 1.30 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>-0.20 ( -0.73 , 0.33 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>5.40 ( 5.60 )</P>
</TD>
<TD>
<P>6.20 ( 6.20 )</P>
</TD>
<TD>
<P>WMD 95 % CI</P>
</TD>
<TD>
<P>-0.15 ( -0.60 , 0.30 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>6.30 ( 5.70 )</P>
</TD>
<TD>
<P>6.10 ( 6.90 )</P>
</TD>
<TD>
<P>WMD 95%CI</P>
</TD>
<TD>
<P>0.20 ( -1.64 , 2.04 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Scott 2006</P>
</TD>
<TD>
<P>Eighteen</P>
</TD>
<TD>
<P>90</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>1.70 ( 2.60 )</P>
</TD>
<TD>
<P>2.00 ( 3.90 )</P>
</TD>
<TD>
<P>WMD 95%CI</P>
</TD>
<TD>
<P>-0.30 ( -1.26 , 0.66 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-22" NO="22">
<TITLE>MRC perfomance score (Mean, SD)</TITLE>
<TABLE COLS="8" ROWS="3">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Score at ( months )</P>
</TH>
<TH>
<P>No in C group</P>
</TH>
<TH>
<P>No in T group</P>
</TH>
<TH>
<P>Control group score</P>
</TH>
<TH>
<P>Treatment group scor</P>
</TH>
<TH>
<P>Statistical method</P>
</TH>
<TH>
<P>Effect Size</P>
</TH>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>Six</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>0.31 ( 0.27 )</P>
</TD>
<TD>
<P>0.10 ( 0.11 )</P>
</TD>
<TD>
<P>WMD 95%CI</P>
</TD>
<TD>
<P>0.21 ( 0.04 , 0.38 )</P>
</TD>
</TR>
<TR>
<TD>
<P>Lam 2000</P>
</TD>
<TD>
<P>Twelve</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>0.33 ( 0.29 )</P>
</TD>
<TD>
<P>0.09 ( 0.16 )</P>
</TD>
<TD>
<P>WMD 95% CI</P>
</TD>
<TD>
<P>0.24 ( 0.05 , 0.43 )</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Treatment as usual (TAU) versus TAU and additional early warning sign recognition</NAME>
<IV_OUTCOME CHI2="16.22802427786402" CI_END="0.8225031782649257" CI_START="0.3937117586538509" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.5690599026579414" ESTIMABLE="YES" I2="69.1891020472511" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.08486241520138942" LOG_CI_START="-0.40482161431258407" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.24484201475698675" NO="1" P_CHI2="0.006222349235166402" P_Q="1.0" P_Z="0.0027029707019428665" Q="0.0" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.14231819709801366" TOTALS="YES" TOTAL_1="367" TOTAL_2="323" WEIGHT="100.0" Z="2.9996420303524167">
<NAME>Time to first recurrence of any type</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU +Early warning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_DATA CI_END="0.6275250622023787" CI_START="0.17621889573009486" EFFECT_SIZE="0.3325383789944587" ESTIMABLE="YES" ESTIMATE="-1.101" LOG_CI_END="-0.20236892457386688" LOG_CI_START="-0.7539475245770935" LOG_EFFECT_SIZE="-0.4781582245754802" ORDER="9823" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="25" TOTAL_2="25" WEIGHT="14.284021019268398"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9824" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="60" TOTAL_2="60" WEIGHT="18.991240631161048"/>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9825" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="51" TOTAL_2="47" WEIGHT="16.126001866668766"/>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9826" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="70" TOTAL_2="31" WEIGHT="14.172097220824794"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9827" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="33" WEIGHT="16.126001866668766"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9828" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="126" TOTAL_2="127" WEIGHT="20.300637395408227"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="9.287134935555615" CI_END="1.0648713854342422" CI_START="0.4043213122244488" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.6561632387668784" ESTIMABLE="YES" I2="67.69724978890359" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.027297157099423847" LOG_CI_START="-0.39327336591952966" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18298810441005292" NO="2" P_CHI2="0.0257071661861209" P_Q="1.0" P_Z="0.0880936087009511" Q="0.0" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.1621523516012761" TOTALS="YES" TOTAL_1="267" TOTAL_2="266" WEIGHT="100.00000000000001" Z="1.7055408052304029">
<NAME>Time to manic/hypomanic episode</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + Early warning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_DATA CI_END="0.8233545018435156" CI_START="0.3290217001851342" EFFECT_SIZE="0.5204819862892832" ESTIMABLE="YES" ESTIMATE="-0.653" LOG_CI_END="-0.08441313557054715" LOG_CI_START="-0.48277545779509967" LOG_EFFECT_SIZE="-0.2835942966828235" ORDER="9829" SE="0.234" STUDY_ID="STD-Colom-2003c" TOTAL_1="60" TOTAL_2="60" WEIGHT="28.136922294672004"/>
<IV_DATA CI_END="1.3274084546869696" CI_START="0.3801351197906488" EFFECT_SIZE="0.7103482047091773" ESTIMABLE="YES" ESTIMATE="-0.342" LOG_CI_END="0.12300457947462695" LOG_CI_START="-0.42006200509645125" LOG_EFFECT_SIZE="-0.14852871281091212" ORDER="9830" SE="0.319" STUDY_ID="STD-Lam-2005" TOTAL_1="46" TOTAL_2="46" WEIGHT="23.125519785339232"/>
<IV_DATA CI_END="0.772708532437696" CI_START="0.18047795560778984" EFFECT_SIZE="0.37343922693666093" ESTIMABLE="YES" ESTIMATE="-0.985" LOG_CI_END="-0.1119842921419915" LOG_CI_START="-0.7435758372074146" LOG_EFFECT_SIZE="-0.42778006467470303" ORDER="9831" SE="0.371" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="33" WEIGHT="20.357801136923285"/>
<IV_DATA CI_END="1.8199184937721529" CI_START="0.738752950438656" EFFECT_SIZE="1.159512896362974" ESTIMABLE="YES" ESTIMATE="0.148" LOG_CI_END="0.2600519382610981" LOG_CI_START="-0.13150077161773563" LOG_EFFECT_SIZE="0.06427558332168128" ORDER="9832" SE="0.23" STUDY_ID="STD-Scott-2006" TOTAL_1="126" TOTAL_2="127" WEIGHT="28.379756783065485"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="11.96652798651574" CI_END="0.9855911426275425" CI_START="0.32728755197385206" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.5679539702455473" ESTIMABLE="YES" I2="74.93007158483651" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.006303208107071941" LOG_CI_START="-0.485070512296252" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.24568686020166197" NO="3" P_CHI2="0.0074987169730631464" P_Q="1.0" P_Z="0.044265097404307355" Q="0.0" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.23172666086043425" TOTALS="YES" TOTAL_1="269" TOTAL_2="264" WEIGHT="99.99999999999999" Z="2.011571772995217">
<NAME>Time to depressive episode</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + Early warning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_DATA CI_END="0.6170724815839151" CI_START="0.23710997588009983" EFFECT_SIZE="0.38251018447178037" ESTIMABLE="YES" ESTIMATE="-0.961" LOG_CI_END="-0.20966382056460015" LOG_CI_START="-0.6250501736534498" LOG_EFFECT_SIZE="-0.417356997109025" ORDER="9833" SE="0.244" STUDY_ID="STD-Colom-2003c" TOTAL_1="60" TOTAL_2="60" WEIGHT="27.154346746568457"/>
<IV_DATA CI_END="0.758712232755848" CI_START="0.19016421577746873" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.11992291372750362" LOG_CI_START="-0.7208712032371919" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9834" SE="0.353" STUDY_ID="STD-Lam-2005" TOTAL_1="48" TOTAL_2="44" WEIGHT="22.195497549233885"/>
<IV_DATA CI_END="1.2745932020050816" CI_START="0.3120390089039157" EFFECT_SIZE="0.6306526773980541" ESTIMABLE="YES" ESTIMATE="-0.461" LOG_CI_END="0.10537159785673415" LOG_CI_START="-0.5057911101715324" LOG_EFFECT_SIZE="-0.2002097561573991" ORDER="9835" SE="0.359" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="33" WEIGHT="21.93255481167783"/>
<IV_DATA CI_END="1.5661689416757518" CI_START="0.6902975981079765" EFFECT_SIZE="1.0397704836501578" ESTIMABLE="YES" ESTIMATE="0.039" LOG_CI_END="0.1948386073261317" LOG_CI_START="-0.1609636377376781" LOG_EFFECT_SIZE="0.0169374847942268" ORDER="9836" SE="0.209" STUDY_ID="STD-Scott-2006" TOTAL_1="126" TOTAL_2="127" WEIGHT="28.71760089251983"/>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="3.0305100569385868" CI_END="0.9488775633199005" CI_START="0.4733214591716313" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6701672275229499" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="62" I2="1.0067630981369502" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.022789822351400355" LOG_CI_START="-0.3248438052963009" LOG_EFFECT_SIZE="-0.1738168138238506" METHOD="MH" NO="4" P_CHI2="0.38694522210513815" P_Q="0.0" P_Z="0.02408813496081943" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="330" TOTAL_2="349" WEIGHT="100.0" Z="2.255720594582562">
<NAME>Percentage of people hospitalised</NAME>
<GROUP_LABEL_1>TAU + Early warning</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9270876321967806" CI_START="0.05326650290045169" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.03287921258610366" LOG_CI_START="-1.2735458149645837" LOG_EFFECT_SIZE="-0.6532125137753437" ORDER="9837" O_E="0.0" SE="0.7287737036358481" STUDY_ID="STD-Colom-2003b" TOTAL_1="25" TOTAL_2="25" VAR="0.5311111111111111" WEIGHT="14.777477121334403"/>
<DICH_DATA CI_END="1.183354959798864" CI_START="0.3755799904028687" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="21" LOG_CI_END="0.07311503537950335" LOG_CI_START="-0.42529755349086584" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="9838" O_E="0.0" SE="0.29277002188455997" STUDY_ID="STD-Colom-2003c" TOTAL_1="60" TOTAL_2="60" VAR="0.08571428571428572" WEIGHT="34.48077994978028"/>
<DICH_DATA CI_END="1.533191361622992" CI_START="0.4695607842104347" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.18559636366734197" LOG_CI_START="-0.3283081807386785" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="9839" O_E="0.0" SE="0.3018700732526183" STUDY_ID="STD-Perry-1999" TOTAL_1="33" TOTAL_2="35" VAR="0.09112554112554112" WEIGHT="23.904742402158593"/>
<DICH_DATA CI_END="1.5586309765214534" CI_START="0.37301009790160944" EFFECT_SIZE="0.7624861265260822" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="17" LOG_CI_END="0.19274330323811312" LOG_CI_START="-0.42827941107713824" LOG_EFFECT_SIZE="-0.11776805391951253" ORDER="9840" O_E="0.0" SE="0.3647918165007931" STUDY_ID="STD-Simon-2004" TOTAL_1="212" TOTAL_2="229" VAR="0.13307306938594832" WEIGHT="26.837000526726726"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.1116674379408282" CI_END="2.095714033802258" CI_START="0.30373330228963735" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.1997236680459478" ESTIMABLE="YES" I2="35.72577918790972" I2_Q="35.72577918790972" ID="CMP-001.05" NO="5" P_CHI2="0.21101348396330755" P_Q="0.21101348396330755" P_Z="0.00868080178747494" Q="3.1116674379408282" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.2241184560788006" TOTALS="YES" TOTAL_1="105" TOTAL_2="102" UNITS="" WEIGHT="100.00000000000001" Z="2.6243755185754734">
<NAME>Measure of functioning</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + Early warning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.6182215308005419" CI_START="-0.7582215308005417" DF="0.0" EFFECT_SIZE="0.43000000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" NO="1" P_CHI2="1.0" P_Z="0.4781493083822653" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="34" WEIGHT="35.321824049470024" Z="0.7092823110050979">
<NAME>MRC social perfomance scale at 6 months</NAME>
<CONT_DATA CI_END="1.6182215308005419" CI_START="-0.7582215308005417" EFFECT_SIZE="0.43000000000000005" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="-0.23" ORDER="9841" SD_1="2.43" SD_2="2.6" SE="0.6062466148220486" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="34" WEIGHT="35.321824049470024"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.5547242698203068" CI_START="-0.07472426982030678" DF="0.0" EFFECT_SIZE="1.24" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.02" NO="2" P_CHI2="1.0" P_Z="0.06452042285016754" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="34" WEIGHT="31.002772820851273" Z="1.8485665752270948">
<NAME>MRC social perfomance scale at 12 months</NAME>
<CONT_DATA CI_END="2.5547242698203068" CI_START="-0.07472426982030678" EFFECT_SIZE="1.24" ESTIMABLE="YES" MEAN_1="0.77" MEAN_2="-0.47" ORDER="9842" SD_1="2.9" SD_2="2.67" SE="0.6707900146077601" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="34" WEIGHT="31.002772820851273"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.2435965524810291E-31" CI_END="3.2040949120107043" CI_START="0.7359050879892952" DF="0.0" EFFECT_SIZE="1.9699999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-001.05.03" NO="3" P_CHI2="0.0" P_Z="0.0017557358301377377" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="34" WEIGHT="33.67540312967872" Z="3.1287132067119443">
<NAME>MRC social perfomance scale at 18 months</NAME>
<CONT_DATA CI_END="3.2040949120107047" CI_START="0.7359050879892954" EFFECT_SIZE="1.97" ESTIMABLE="YES" MEAN_1="0.94" MEAN_2="-1.03" ORDER="9843" SD_1="2.68" SD_2="2.55" SE="0.6296518312301081" STUDY_ID="STD-Perry-1999" TOTAL_1="35" TOTAL_2="34" WEIGHT="33.67540312967872"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Heterogeneity</NAME>
<IV_OUTCOME CHI2="12.551945303486532" CI_END="0.9134549705355807" CI_START="0.47757936491160385" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.6604901548878155" ESTIMABLE="YES" I2="60.16553706132579" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.039312856663854624" LOG_CI_START="-0.32095444632305165" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18013365149345312" NO="1" P_CHI2="0.02795960090628702" P_Q="0.42537956193311177" P_Z="0.012171733100600367" Q="0.6354058271660996" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0957229173697046" TOTALS="YES" TOTAL_1="6" TOTAL_2="6" WEIGHT="100.0" Z="2.5071259522293987">
<NAME>EWS intervention vs psychological control group for time to first recurrence of any type</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="10.02909327466158" CI_END="1.031364227813395" CI_START="0.40845243299876777" DF="3.0" EFFECT_SIZE="0.649047939799732" ESTIMABLE="YES" I2="70.08702663500523" ID="CMP-002.01.01" LOG_CI_END="0.013412064114842677" LOG_CI_START="-0.3888585126664369" LOG_EFFECT_SIZE="-0.18772322427579716" NO="1" P_CHI2="0.018320484505458867" P_Z="0.06735916333698812" STUDIES="4" TAU2="0.15371037732260312" TOTAL_1="4" TOTAL_2="4" WEIGHT="66.72952342268138" Z="1.8292700479674748">
<NAME>EWS intervention</NAME>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9844" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9845" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.505729921836926"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9846" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9847" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.482052314283926"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.887446201658852" CI_END="1.0863792011813707" CI_START="0.3944484668734416" DF="1.0" EFFECT_SIZE="0.6546148564989843" ESTIMABLE="YES" I2="47.01835744398368" ID="CMP-002.01.02" LOG_CI_END="0.035981442412653226" LOG_CI_START="-0.4040097275987968" LOG_EFFECT_SIZE="-0.18401414259307178" NO="2" P_CHI2="0.16949046364998677" P_Z="0.10112966938830743" STUDIES="2" TAU2="0.065962545" TOTAL_1="2" TOTAL_2="2" WEIGHT="33.27047657731861" Z="1.639401500348532">
<NAME>psychological control group</NAME>
<IV_DATA CI_END="1.705789973487358" CI_START="0.479012622094236" EFFECT_SIZE="0.9039330328858641" ESTIMABLE="YES" ESTIMATE="-0.101" LOG_CI_END="0.23192555732938494" LOG_CI_START="-0.31965304267384176" LOG_EFFECT_SIZE="-0.04386374267222841" ORDER="9848" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.637154101314485"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9849" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="19.63332247600413"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="9.536263722370093" CI_END="1.0291742140952187" CI_START="0.4104479895439447" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.6499403719310348" ESTIMABLE="YES" I2="68.54113846534442" I2_Q="65.7075062838805" ID="CMP-002.02" LOG_CI_END="0.012488896449650457" LOG_CI_START="-0.3867418672537498" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18712648540204962" NO="2" P_CHI2="0.022948767362750644" P_Q="0.08770028113600037" P_Z="0.06615983198750205" Q="2.91609005830317" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.14585222564188444" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="1.8373392297696511">
<NAME>EWS intervention vs psychological control group for time to manic/hypomanic episode</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU +EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="6.620173664066923" CI_END="1.2534641878451822" CI_START="0.38944156413018893" DF="2.0" EFFECT_SIZE="0.6986780760089762" ESTIMABLE="YES" I2="69.78931216176956" ID="CMP-002.02.01" LOG_CI_END="0.0981119304415034" LOG_CI_START="-0.40955769917171686" LOG_EFFECT_SIZE="-0.1557228843651067" NO="1" P_CHI2="0.03651308937518627" P_Z="0.22920820898556193" STUDIES="3" TAU2="0.18399585005311966" TOTAL_1="3" TOTAL_2="3" WEIGHT="72.58587009240475" Z="1.2024010384739259">
<NAME>EWS intervention</NAME>
<IV_DATA CI_END="1.3274084546869696" CI_START="0.3801351197906488" EFFECT_SIZE="0.7103482047091773" ESTIMABLE="YES" ESTIMATE="-0.342" LOG_CI_END="0.12300457947462695" LOG_CI_START="-0.42006200509645125" LOG_EFFECT_SIZE="-0.14852871281091212" ORDER="9850" SE="0.319" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="22.210041261013103"/>
<IV_DATA CI_END="0.772708532437696" CI_START="0.18047795560778984" EFFECT_SIZE="0.37343922693666093" ESTIMABLE="YES" ESTIMATE="-0.985" LOG_CI_END="-0.1119842921419915" LOG_CI_START="-0.7435758372074146" LOG_EFFECT_SIZE="-0.42778006467470303" ORDER="9851" SE="0.371" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="19.39905246704521"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9852" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="30.97677636434644"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.8233545018435156" CI_START="0.3290217001851342" DF="0.0" EFFECT_SIZE="0.5204819862892832" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="-0.08441313557054715" LOG_CI_START="-0.48277545779509967" LOG_EFFECT_SIZE="-0.2835942966828235" NO="2" P_CHI2="1.0" P_Z="0.005261072338132531" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.414129907595253" Z="2.7905982905982905">
<NAME>Psychological control group</NAME>
<IV_DATA CI_END="0.8233545018435156" CI_START="0.3290217001851342" EFFECT_SIZE="0.5204819862892832" ESTIMABLE="YES" ESTIMATE="-0.653" LOG_CI_END="-0.08441313557054715" LOG_CI_START="-0.48277545779509967" LOG_EFFECT_SIZE="-0.2835942966828235" ORDER="9853" SE="0.234" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.414129907595253"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="11.966527986515738" CI_END="0.9855911426275425" CI_START="0.32728755197385206" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.5679539702455474" ESTIMABLE="YES" I2="74.93007158483651" I2_Q="82.10367190377231" ID="CMP-002.03" LOG_CI_END="-0.006303208107071941" LOG_CI_START="-0.485070512296252" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.24568686020166192" NO="3" P_CHI2="0.0074987169730631464" P_Q="0.018086750367270032" P_Z="0.044265097404307355" Q="5.587738415517687" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.2317266608604342" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="2.011571772995217">
<NAME>EWS intervention vs psychological control group for time to depressive episode</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU +EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>FavoursControl</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="6.378789570998051" CI_END="1.2211200054578009" CI_START="0.3584774718981203" DF="2.0" EFFECT_SIZE="0.6616222581206979" ESTIMABLE="YES" I2="68.64608907788327" ID="CMP-002.03.01" LOG_CI_END="0.08675834629304445" LOG_CI_START="-0.4455381318727625" LOG_EFFECT_SIZE="-0.17938989278985898" NO="1" P_CHI2="0.04119684764220888" P_Z="0.18648143876053266" STUDIES="3" TAU2="0.19989702578650004" TOTAL_1="3" TOTAL_2="3" WEIGHT="72.84565325343154" Z="1.3210597607940766">
<NAME>EWS intervention</NAME>
<IV_DATA CI_END="0.758712232755848" CI_START="0.19016421577746873" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.11992291372750362" LOG_CI_START="-0.7208712032371919" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9854" SE="0.353" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="22.195497549233885"/>
<IV_DATA CI_END="1.2745932020050816" CI_START="0.3120390089039157" EFFECT_SIZE="0.6306526773980541" ESTIMABLE="YES" ESTIMATE="-0.461" LOG_CI_END="0.10537159785673415" LOG_CI_START="-0.5057911101715324" LOG_EFFECT_SIZE="-0.2002097561573991" ORDER="9855" SE="0.359" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.93255481167783"/>
<IV_DATA CI_END="1.5661689416757518" CI_START="0.6902975981079765" EFFECT_SIZE="1.0397704836501578" ESTIMABLE="YES" ESTIMATE="0.039" LOG_CI_END="0.1948386073261317" LOG_CI_START="-0.1609636377376781" LOG_EFFECT_SIZE="0.0169374847942268" ORDER="9856" SE="0.209" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="28.717600892519823"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="2.0703358714186896E-31" CI_END="0.6170724815839153" CI_START="0.23710997588009983" DF="0.0" EFFECT_SIZE="0.3825101844717804" ESTIMABLE="YES" I2="100.0" ID="CMP-002.03.02" LOG_CI_END="-0.2096638205646001" LOG_CI_START="-0.6250501736534498" LOG_EFFECT_SIZE="-0.41735699710902496" NO="2" P_CHI2="0.0" P_Z="8.198419302989725E-5" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.154346746568457" Z="3.938524590163934">
<NAME>psychological control group</NAME>
<IV_DATA CI_END="0.6170724815839151" CI_START="0.23710997588009983" EFFECT_SIZE="0.38251018447178037" ESTIMABLE="YES" ESTIMATE="-0.961" LOG_CI_END="-0.20966382056460015" LOG_CI_START="-0.6250501736534498" LOG_EFFECT_SIZE="-0.417356997109025" ORDER="9857" SE="0.244" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.154346746568457"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="10.029093274661582" CI_END="1.031364227813395" CI_START="0.40845243299876777" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.649047939799732" ESTIMABLE="YES" I2="70.08702663500523" I2_Q="79.1016903323754" ID="CMP-002.04" LOG_CI_END="0.013412064114842677" LOG_CI_START="-0.3888585126664369" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18772322427579716" NO="4" P_CHI2="0.018320484505458978" P_Q="0.028707481218502973" P_Z="0.06735916333698816" Q="4.785075998510959" RANDOM="YES" SCALE="2.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.15371037732260323" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="99.99999999999999" Z="1.8292700479674746">
<NAME>Time to first recurrence of any type for TAU Vs enhanced TAU</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="5.244017276150623" CI_END="1.1822945813177022" CI_START="0.48827057058618284" DF="2.0" EFFECT_SIZE="0.759789214072526" ESTIMABLE="YES" I2="61.861300322257854" ID="CMP-002.04.01" LOG_CI_END="0.07272569913511413" LOG_CI_START="-0.31133945105315425" LOG_EFFECT_SIZE="-0.11930687595902001" NO="1" P_CHI2="0.07265690119921897" P_Z="0.2233397750851841" STUDIES="3" TAU2="0.09417520743807453" TOTAL_1="3" TOTAL_2="3" WEIGHT="78.57742307435699" Z="1.2176953825310117">
<NAME>Studies including only TAU</NAME>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9858" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="24.230091121659527"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9859" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="24.230091121659527"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9860" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="30.117240831037936"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.1527229885324195E-31" CI_END="0.721017567120735" CI_START="0.20010596595995053" DF="0.0" EFFECT_SIZE="0.37984196285137867" ESTIMABLE="YES" I2="100.0" ID="CMP-002.04.02" LOG_CI_END="-0.14205415385108985" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.4203970584823478" NO="2" P_CHI2="0.0" P_Z="0.0030739482990345757" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.422576925643" Z="2.960244648318043">
<NAME>Studies including enhanced TAU</NAME>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9861" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.422576925643"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="12.55194530348653" CI_END="0.9134549705355807" CI_START="0.47757936491160385" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.6604901548878155" ESTIMABLE="YES" I2="60.165537061325786" I2_Q="72.65344624302823" ID="CMP-002.05" LOG_CI_END="-0.039312856663854624" LOG_CI_START="-0.32095444632305165" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18013365149345312" NO="5" P_CHI2="0.02795960090628702" P_Q="0.05584206636993594" P_Z="0.012171733100600367" Q="3.656767901677771" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0957229173697046" TOTALS="YES" TOTAL_1="6" TOTAL_2="6" WEIGHT="100.0" Z="2.5071259522293987">
<NAME>Time to first recurrence of any type for Intervention delivered in groups vs individually</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="5.244017276150623" CI_END="1.1822945813177022" CI_START="0.4882705705861828" DF="2.0" EFFECT_SIZE="0.7597892140725259" ESTIMABLE="YES" I2="61.861300322257854" ID="CMP-002.05.01" LOG_CI_END="0.07272569913511413" LOG_CI_START="-0.3113394510531543" LOG_EFFECT_SIZE="-0.11930687595902006" NO="1" P_CHI2="0.07265690119921897" P_Z="0.2233397750851841" STUDIES="3" TAU2="0.09417520743807456" TOTAL_1="3" TOTAL_2="3" WEIGHT="53.223793500844465" Z="1.2176953825310115">
<NAME>intervention delivered individually</NAME>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9862" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9863" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9864" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.482052314283926"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="3.651160125658137" CI_END="0.8651481155935841" CI_START="0.36571312094083297" DF="2.0" EFFECT_SIZE="0.5624909043085142" ESTIMABLE="YES" I2="45.22288995365572" ID="CMP-002.05.02" LOG_CI_END="-0.06290953383195712" LOG_CI_START="-0.43685945790100933" LOG_EFFECT_SIZE="-0.24988449586648323" NO="2" P_CHI2="0.16112422921129632" P_Z="0.008808128396324583" STUDIES="3" TAU2="0.06615726689186813" TOTAL_1="3" TOTAL_2="3" WEIGHT="46.776206499155535" Z="2.6194128179730134">
<NAME>intervention delivered in groups</NAME>
<IV_DATA CI_END="1.705789973487358" CI_START="0.479012622094236" EFFECT_SIZE="0.9039330328858641" ESTIMABLE="YES" ESTIMATE="-0.101" LOG_CI_END="0.23192555732938494" LOG_CI_START="-0.31965304267384176" LOG_EFFECT_SIZE="-0.04386374267222841" ORDER="9865" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.637154101314485"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9866" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="19.63332247600413"/>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9867" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.505729921836926"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="12.551945303486532" CI_END="0.9134549705355807" CI_START="0.47757936491160385" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.6604901548878155" ESTIMABLE="YES" I2="60.16553706132579" I2_Q="53.92306098928986" ID="CMP-002.06" LOG_CI_END="-0.039312856663854624" LOG_CI_START="-0.32095444632305165" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18013365149345312" NO="6" P_CHI2="0.02795960090628702" P_Q="0.1407004079764793" P_Z="0.012171733100600367" Q="2.1702830558417947" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0957229173697046" TOTALS="YES" TOTAL_1="6" TOTAL_2="6" WEIGHT="100.0" Z="2.5071259522293987">
<NAME>Inclusion one month after episode vs recruitment during episode</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="2.9199595213492238" CI_END="0.7965747251630153" CI_START="0.4771103499840048" DF="3.0" EFFECT_SIZE="0.6164852357607103" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="-0.09877347761081585" LOG_CI_START="-0.32138116216212564" LOG_EFFECT_SIZE="-0.21007731988647077" NO="1" P_CHI2="0.4041313350791693" P_Z="2.1621270610325106E-4" STUDIES="4" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="65.01221776387915" Z="3.6992791311413895">
<NAME>Time to first recurrence of any type for studies recruiting one month after episode</NAME>
<IV_DATA CI_END="1.705789973487358" CI_START="0.479012622094236" EFFECT_SIZE="0.9039330328858641" ESTIMABLE="YES" ESTIMATE="-0.101" LOG_CI_END="0.23192555732938494" LOG_CI_START="-0.31965304267384176" LOG_EFFECT_SIZE="-0.04386374267222841" ORDER="9868" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.637154101314485"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9869" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="19.63332247600413"/>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9870" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9871" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="15.87087059328027"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="7.4617027262955125" CI_END="1.7709114689852918" CI_START="0.24255976364059" DF="1.0" EFFECT_SIZE="0.6554020654113645" ESTIMABLE="YES" I2="86.5982331824084" ID="CMP-002.06.02" LOG_CI_END="0.24819685057900515" LOG_CI_START="-0.6151812392408073" LOG_EFFECT_SIZE="-0.18349219433090105" NO="2" P_CHI2="0.006302576798768222" P_Z="0.404791020967209" STUDIES="2" TAU2="0.44783799999999996" TOTAL_1="2" TOTAL_2="2" WEIGHT="34.98778223612085" Z="0.8330952489374557">
<NAME>Time to first recurrence of any type for studies recruiting people during episode</NAME>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9872" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.505729921836926"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9873" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.482052314283926"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="16.228024277864016" CI_END="0.8225031782649257" CI_START="0.3937117586538509" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.5690599026579414" ESTIMABLE="YES" I2="69.18910204725108" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-0.08486241520138942" LOG_CI_START="-0.40482161431258407" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.24484201475698675" NO="7" P_CHI2="0.006222349235166513" P_Q="0.5355576931451831" P_Z="0.0027029707019428665" Q="0.3838360641615335" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1423181970980136" TOTALS="YES" TOTAL_1="6" TOTAL_2="6" WEIGHT="100.0" Z="2.9996420303524167">
<NAME>Time to first recurrence of any type for simple VS complex intervention for EWS</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU +EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.2800639322027276" CI_START="0.43218133420015686" DF="0.0" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" NO="1" P_CHI2="1.0" P_Z="0.28525354492165567" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="16.126001866668766" Z="1.0685920577617327">
<NAME>Simple intervention for EWS</NAME>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9874" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="16.126001866668766"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="15.844188213702482" CI_END="0.8317894752541075" CI_START="0.3450238583307497" DF="4.0" EFFECT_SIZE="0.5357118759847329" ESTIMABLE="YES" I2="74.75414993782583" ID="CMP-002.07.02" LOG_CI_END="-0.07998657912374466" LOG_CI_START="-0.4621508725118432" LOG_EFFECT_SIZE="-0.27106872581779395" NO="2" P_CHI2="0.003235533584526218" P_Z="0.005429185628656469" STUDIES="5" TAU2="0.1829687969355367" TOTAL_1="5" TOTAL_2="5" WEIGHT="83.87399813333124" Z="2.7804007288483343">
<NAME>Complex intervention for EWS</NAME>
<IV_DATA CI_END="0.6275250622023787" CI_START="0.17621889573009486" EFFECT_SIZE="0.3325383789944587" ESTIMABLE="YES" ESTIMATE="-1.101" LOG_CI_END="-0.20236892457386688" LOG_CI_START="-0.7539475245770935" LOG_EFFECT_SIZE="-0.4781582245754802" ORDER="9875" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="1" TOTAL_2="1" WEIGHT="14.2840210192684"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9876" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="18.99124063116105"/>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9877" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="16.126001866668766"/>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9878" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="14.172097220824796"/>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9879" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="20.30063739540823"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="9.287134935555613" CI_END="1.0648713854342422" CI_START="0.4043213122244488" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.6561632387668784" ESTIMABLE="YES" I2="67.69724978890359" I2_Q="69.27964022504685" ID="CMP-002.08" LOG_CI_END="0.027297157099423847" LOG_CI_START="-0.39327336591952966" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.18298810441005292" NO="8" P_CHI2="0.02570716618612101" P_Q="0.07119860234075115" P_Z="0.0880936087009511" Q="3.2551702106539704" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.1621523516012761" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.00000000000001" Z="1.7055408052304029">
<NAME>Time to manic/hypomanic episode for simple Vs complex intervention for EWS</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="0.772708532437696" CI_START="0.18047795560778984" DF="0.0" EFFECT_SIZE="0.37343922693666093" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="-0.1119842921419915" LOG_CI_START="-0.7435758372074146" LOG_EFFECT_SIZE="-0.42778006467470303" NO="1" P_CHI2="1.0" P_Z="0.007931157712776487" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="20.357801136923285" Z="2.6549865229110514">
<NAME>Simple intervention for EWS</NAME>
<IV_DATA CI_END="0.772708532437696" CI_START="0.18047795560778984" EFFECT_SIZE="0.37343922693666093" ESTIMABLE="YES" ESTIMATE="-0.985" LOG_CI_END="-0.1119842921419915" LOG_CI_START="-0.7435758372074146" LOG_EFFECT_SIZE="-0.42778006467470303" ORDER="9880" SE="0.371" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="20.357801136923285"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="6.031964724901643" CI_END="1.2592705068556753" CI_START="0.4567328444104377" DF="2.0" EFFECT_SIZE="0.758386577200814" ESTIMABLE="YES" I2="66.84330742612869" ID="CMP-002.08.02" LOG_CI_END="0.100119031947255" LOG_CI_START="-0.34033775643914993" LOG_EFFECT_SIZE="-0.12010936224594743" NO="2" P_CHI2="0.04899781145353055" P_Z="0.28509859567268536" STUDIES="3" TAU2="0.13334606700745405" TOTAL_1="3" TOTAL_2="3" WEIGHT="79.64219886307673" Z="1.0689358430394351">
<NAME>Complex intervention for EWS</NAME>
<IV_DATA CI_END="0.8233545018435156" CI_START="0.3290217001851342" EFFECT_SIZE="0.5204819862892832" ESTIMABLE="YES" ESTIMATE="-0.653" LOG_CI_END="-0.08441313557054715" LOG_CI_START="-0.48277545779509967" LOG_EFFECT_SIZE="-0.2835942966828235" ORDER="9881" SE="0.234" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="28.136922294672004"/>
<IV_DATA CI_END="1.3274084546869696" CI_START="0.3801351197906488" EFFECT_SIZE="0.7103482047091773" ESTIMABLE="YES" ESTIMATE="-0.342" LOG_CI_END="0.12300457947462695" LOG_CI_START="-0.42006200509645125" LOG_EFFECT_SIZE="-0.14852871281091212" ORDER="9882" SE="0.319" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="23.125519785339232"/>
<IV_DATA CI_END="1.8199184937721529" CI_START="0.738752950438656" EFFECT_SIZE="1.159512896362974" ESTIMABLE="YES" ESTIMATE="0.148" LOG_CI_END="0.2600519382610981" LOG_CI_START="-0.13150077161773563" LOG_EFFECT_SIZE="0.06427558332168128" ORDER="9883" SE="0.23" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="28.379756783065485"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="11.96652798651574" CI_END="0.9855911426275425" CI_START="0.32728755197385206" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.5679539702455473" ESTIMABLE="YES" I2="74.93007158483651" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-0.006303208107071941" LOG_CI_START="-0.485070512296252" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.24568686020166197" NO="9" P_CHI2="0.0074987169730631464" P_Q="0.9559429213783618" P_Z="0.044265097404307355" Q="0.003052063393491622" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.23172666086043425" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="2.011571772995217">
<NAME>Time to depressive episode for simple Vs complex intervention for EWS</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.2745932020050816" CI_START="0.3120390089039157" DF="0.0" EFFECT_SIZE="0.6306526773980541" ESTIMABLE="YES" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.10537159785673415" LOG_CI_START="-0.5057911101715324" LOG_EFFECT_SIZE="-0.2002097561573991" NO="1" P_CHI2="1.0" P_Z="0.19909907460135984" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.93255481167783" Z="1.2841225626740949">
<NAME>Simple intervention for EWS</NAME>
<IV_DATA CI_END="1.2745932020050816" CI_START="0.3120390089039157" EFFECT_SIZE="0.6306526773980541" ESTIMABLE="YES" ESTIMATE="-0.461" LOG_CI_END="0.10537159785673415" LOG_CI_START="-0.5057911101715324" LOG_EFFECT_SIZE="-0.2002097561573991" ORDER="9884" SE="0.359" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="21.93255481167783"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="11.963475923122248" CI_END="1.1293193647946778" CI_START="0.2645595743820729" DF="2.0" EFFECT_SIZE="0.5466006316237778" ESTIMABLE="YES" I2="83.28245057830955" ID="CMP-002.09.02" LOG_CI_END="0.05281677518861472" LOG_CI_START="-0.5774765167776987" LOG_EFFECT_SIZE="-0.26232987079454206" NO="2" P_CHI2="0.0025244406574259637" P_Z="0.10278797347982675" STUDIES="3" TAU2="0.33810636910405306" TOTAL_1="3" TOTAL_2="3" WEIGHT="78.06744518832217" Z="1.6314852319698423">
<NAME>Complex intervention for EWS</NAME>
<IV_DATA CI_END="0.6170724815839151" CI_START="0.23710997588009983" EFFECT_SIZE="0.38251018447178037" ESTIMABLE="YES" ESTIMATE="-0.961" LOG_CI_END="-0.20966382056460015" LOG_CI_START="-0.6250501736534498" LOG_EFFECT_SIZE="-0.417356997109025" ORDER="9885" SE="0.244" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.154346746568457"/>
<IV_DATA CI_END="0.758712232755848" CI_START="0.19016421577746873" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.11992291372750362" LOG_CI_START="-0.7208712032371919" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9886" SE="0.353" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="22.195497549233885"/>
<IV_DATA CI_END="1.5661689416757518" CI_START="0.6902975981079765" EFFECT_SIZE="1.0397704836501578" ESTIMABLE="YES" ESTIMATE="0.039" LOG_CI_END="0.1948386073261317" LOG_CI_START="-0.1609636377376781" LOG_EFFECT_SIZE="0.0169374847942268" ORDER="9887" SE="0.209" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="28.71760089251983"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="12.551945303486532" CI_END="0.8491295390345144" CI_START="0.5730855633897287" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_SIZE="0.6975843176766915" ESTIMABLE="YES" I2="60.16553706132579" I2_Q="87.08187747759435" ID="CMP-002.10" LOG_CI_END="-0.071026050867433" LOG_CI_START="-0.24178053172572306" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.15640329129657804" NO="10" P_CHI2="0.02795960090628702" P_Q="0.005397915377387652" P_Z="3.300763249556008E-4" Q="7.741062977731971" RANDOM="NO" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="6" TOTAL_2="6" WEIGHT="100.0" Z="3.5904746565242167">
<NAME>Time to first recurrence in studies where EWS as primary focus Vs EWS as secondary focus</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="4.8108823257545605" CI_END="0.7316027292176803" CI_START="0.4545490345989609" DF="4.0" EFFECT_SIZE="0.5766708890483909" ESTIMABLE="YES" I2="16.855168570920682" ID="CMP-002.10.01" LOG_CI_END="-0.1357246830726469" LOG_CI_START="-0.3424192602812145" LOG_EFFECT_SIZE="-0.2390719716769307" NO="1" P_CHI2="0.30725852055968506" P_Z="5.788804522140183E-6" STUDIES="5" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="68.24739085536231" Z="4.533959821567507">
<NAME>Studies where EWS is the primary focus</NAME>
<IV_DATA CI_END="1.705789973487358" CI_START="0.479012622094236" EFFECT_SIZE="0.9039330328858641" ESTIMABLE="YES" ESTIMATE="-0.101" LOG_CI_END="0.23192555732938494" LOG_CI_START="-0.31965304267384176" LOG_EFFECT_SIZE="-0.04386374267222841" ORDER="9888" SE="0.324" STUDY_ID="STD-Colom-2003b" TOTAL_1="1" TOTAL_2="1" WEIGHT="9.58361595163371"/>
<IV_DATA CI_END="0.8016625444104692" CI_START="0.3533371874349459" EFFECT_SIZE="0.5322191172007424" ESTIMABLE="YES" ESTIMATE="-0.6307" LOG_CI_END="-0.09600840720447602" LOG_CI_START="-0.4518106522682858" LOG_EFFECT_SIZE="-0.27390952973638094" ORDER="9889" SE="0.209" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="23.03174533867586"/>
<IV_DATA CI_END="0.8606305366050286" CI_START="0.29057021622608425" EFFECT_SIZE="0.5000735956957677" ESTIMABLE="YES" ESTIMATE="-0.693" LOG_CI_END="-0.06518324848843839" LOG_CI_START="-0.5367489034294686" LOG_EFFECT_SIZE="-0.30096607595895347" ORDER="9890" SE="0.277" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.111726571944116"/>
<IV_DATA CI_END="0.7210175671207351" CI_START="0.20010596595995053" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.1420541538510898" LOG_CI_START="-0.6987399631136058" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9891" SE="0.327" STUDY_ID="STD-Miklowitz-2003" TOTAL_1="1" TOTAL_2="1" WEIGHT="9.408576421164513"/>
<IV_DATA CI_END="1.2800639322027276" CI_START="0.43218133420015686" EFFECT_SIZE="0.7437874280201796" ESTIMABLE="YES" ESTIMATE="-0.296" LOG_CI_END="0.10723166082715263" LOG_CI_START="-0.3643339941138776" LOG_EFFECT_SIZE="-0.12855116664336252" ORDER="9892" SE="0.277" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.111726571944116"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.4886558359091624" CI_START="0.7409118739892613" DF="0.0" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" I2="0.0" ID="CMP-002.10.02" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" NO="2" P_CHI2="1.0" P_Z="0.78310043858276" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="31.752609144637685" Z="0.2752808988764045">
<NAME>Studies where EWS is the secondary focus</NAME>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9893" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="31.752609144637685"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="9.536263722370093" CI_END="0.9299026193721676" CI_START="0.575872679494641" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.7317824219581497" ESTIMABLE="YES" I2="68.54113846534442" I2_Q="87.17409075238983" ID="CMP-002.11" LOG_CI_END="-0.03156252895538182" LOG_CI_START="-0.23967352474526013" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.13561802685032098" NO="11" P_CHI2="0.022948767362750644" P_Q="0.0052341367477503065" P_Z="0.010635017929288303" Q="7.796718195135587" RANDOM="NO" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="2.5544680834585956">
<NAME>Time to manic episode in studies where EWS as primary focus Vs EWS as secondary focus</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.7395455272345053" CI_END="0.737009062648439" CI_START="0.3812086802162158" DF="2.0" EFFECT_SIZE="0.5300511787361686" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.01" LOG_CI_END="-0.1325271717962949" LOG_CI_START="-0.4188372189280328" LOG_EFFECT_SIZE="-0.2756821953621639" NO="1" P_CHI2="0.4190471211168313" P_Z="1.6038040848810852E-4" STUDIES="3" TAU2="0.0" TOTAL_1="3" TOTAL_2="3" WEIGHT="52.83441189832064" Z="3.774419930434081">
<NAME>studies where EWS is the primary focus</NAME>
<IV_DATA CI_END="0.8233545018435156" CI_START="0.3290217001851342" EFFECT_SIZE="0.5204819862892832" ESTIMABLE="YES" ESTIMATE="-0.653" LOG_CI_END="-0.08441313557054715" LOG_CI_START="-0.48277545779509967" LOG_EFFECT_SIZE="-0.2835942966828235" ORDER="9894" SE="0.234" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="27.29188570044577"/>
<IV_DATA CI_END="1.3274084546869696" CI_START="0.3801351197906488" EFFECT_SIZE="0.7103482047091773" ESTIMABLE="YES" ESTIMATE="-0.342" LOG_CI_END="0.12300457947462695" LOG_CI_START="-0.42006200509645125" LOG_EFFECT_SIZE="-0.14852871281091212" ORDER="9895" SE="0.319" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="14.685336164283063"/>
<IV_DATA CI_END="0.772708532437696" CI_START="0.18047795560778984" EFFECT_SIZE="0.37343922693666093" ESTIMABLE="YES" ESTIMATE="-0.985" LOG_CI_END="-0.1119842921419915" LOG_CI_START="-0.7435758372074146" LOG_EFFECT_SIZE="-0.42778006467470303" ORDER="9896" SE="0.371" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="10.8571900335918"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.4886558359091624" CI_START="0.7409118739892613" DF="0.0" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.02" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" NO="2" P_CHI2="1.0" P_Z="0.78310043858276" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="47.16558810167936" Z="0.2752808988764045">
<NAME>Studies where EWS is the secondary focus</NAME>
<IV_DATA CI_END="1.4886558359091624" CI_START="0.7409118739892613" EFFECT_SIZE="1.050220350740028" ESTIMABLE="YES" ESTIMATE="0.049" LOG_CI_END="0.1727943043055037" LOG_CI_START="-0.13023344507898502" LOG_EFFECT_SIZE="0.021280429613259304" ORDER="9897" SE="0.178" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="47.16558810167936"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="11.96652798651574" CI_END="0.8055387921775896" CI_START="0.47590174898347776" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_SIZE="0.6191585581023273" ESTIMABLE="YES" I2="74.93007158483651" I2_Q="90.45349336593138" ID="CMP-002.12" LOG_CI_END="-0.09391354050484102" LOG_CI_START="-0.32248269912543337" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.2081981198151372" NO="12" P_CHI2="0.0074987169730631464" P_Q="0.0012099886008604122" P_Z="3.562085019820606E-4" Q="10.475035930224996" RANDOM="NO" SCALE="5.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="3.5705676036894745">
<NAME>Time to depressive episode in studies where EWS as primary focus Vs EWS as secondary focus</NAME>
<GROUP_LABEL_1>TAU</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU + EWS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazards ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.4914920562907437" CI_END="0.6063636978051619" CI_START="0.3051281416555387" DF="2.0" EFFECT_SIZE="0.4301379177411237" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.01" LOG_CI_END="-0.21726680723555084" LOG_CI_START="-0.5155177359757697" LOG_EFFECT_SIZE="-0.36639227160566024" NO="1" P_CHI2="0.4743803675806484" P_Z="1.4682198615158627E-6" STUDIES="3" TAU2="0.0" TOTAL_1="3" TOTAL_2="3" WEIGHT="58.73157532140658" Z="4.815513296767644">
<NAME>Studies where EWS is the primary focus</NAME>
<IV_DATA CI_END="0.6170724815839151" CI_START="0.23710997588009983" EFFECT_SIZE="0.38251018447178037" ESTIMABLE="YES" ESTIMATE="-0.961" LOG_CI_END="-0.20966382056460015" LOG_CI_START="-0.6250501736534498" LOG_EFFECT_SIZE="-0.417356997109025" ORDER="9898" SE="0.244" STUDY_ID="STD-Colom-2003c" TOTAL_1="1" TOTAL_2="1" WEIGHT="30.278252794706383"/>
<IV_DATA CI_END="0.758712232755848" CI_START="0.19016421577746873" EFFECT_SIZE="0.3798419628513787" ESTIMABLE="YES" ESTIMATE="-0.968" LOG_CI_END="-0.11992291372750362" LOG_CI_START="-0.7208712032371919" LOG_EFFECT_SIZE="-0.42039705848234776" ORDER="9899" SE="0.353" STUDY_ID="STD-Lam-2005" TOTAL_1="1" TOTAL_2="1" WEIGHT="14.466419427052937"/>
<IV_DATA CI_END="1.2745932020050816" CI_START="0.3120390089039157" EFFECT_SIZE="0.6306526773980541" ESTIMABLE="YES" ESTIMATE="-0.461" LOG_CI_END="0.10537159785673415" LOG_CI_START="-0.5057911101715324" LOG_EFFECT_SIZE="-0.2002097561573991" ORDER="9900" SE="0.359" STUDY_ID="STD-Perry-1999" TOTAL_1="1" TOTAL_2="1" WEIGHT="13.986903099647265"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.5661689416757518" CI_START="0.6902975981079765" DF="0.0" EFFECT_SIZE="1.0397704836501578" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.02" LOG_CI_END="0.1948386073261317" LOG_CI_START="-0.1609636377376781" LOG_EFFECT_SIZE="0.0169374847942268" NO="2" P_CHI2="1.0" P_Z="0.8519720157957859" STUDIES="1" TAU2="0.0" TOTAL_1="1" TOTAL_2="1" WEIGHT="41.26842467859342" Z="0.18660287081339713">
<NAME>Studies where EWS is the secondary focus</NAME>
<IV_DATA CI_END="1.5661689416757518" CI_START="0.6902975981079765" EFFECT_SIZE="1.0397704836501578" ESTIMABLE="YES" ESTIMATE="0.039" LOG_CI_END="0.1948386073261317" LOG_CI_START="-0.1609636377376781" LOG_EFFECT_SIZE="0.0169374847942268" ORDER="9901" SE="0.209" STUDY_ID="STD-Scott-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="41.26842467859342"/>
</IV_SUBGROUP>
</IV_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>